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The RNA exosome is a multi-subunit protein complex involved in RNA 
maturation, surveillance, and turnover of cellular RNA.  It is composed of a nine 
subunit core that contains an RNA binding central channel and associates with the 
additional subunit Rrp44.  Rrp44 contains a 3’ to 5’ processive exoribonuclease 
activity and an endoribonuclease activity in its N-terminal PIN domain.  The exosome 
is present in both the nucleus and cytoplasm.  In the nucleus, the exosome associates 
with a second nuclease, Rrp6, which is a distributive 3’ to 5’ exoribonuclease.  
Although a wealth of studies have helped to characterize the exosome, it is still not 
entirely clear how the exosome core functions in concert with these two nucleases to 
degrade RNA. 
In this dissertation, I present structural and biochemical studies of both the Rrp44 
and Rrp6 bound exosome.  In particular, I have attempted to crystallize a sub-complex 
of Rrp44 bound to the exosome, and present data that suggest that structured RNA can 
access Rrp44 without being first channeled through the exosome.  Despite this 
conclusion, the exosome core still appears to down-regulate both the exonuclease and 
endonuclease activities of Rrp44, possibly by causing the protein to assume a 
conformation that prohibits it from promiscuous RNA degradation.  Work on the Rrp6 
containing exosme was conducted in attempts of obtaining an EM reconstruction of 
this complex.  Crystallization of an RNA and Rrp6 binding exosome associated 
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protein, Rrp47, was also attempted alone and in complex with Rrp6.  Overall, the 
results that I present here will help to further characterize the function of the exosome 
in RNA mediated degradation.    
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Chapter 1: Introduction to the RNA exosome 
 
1.1. The Role of the Eukaryotic Exosome in RNA metabolism 
 
Virtually every RNA species in the cell is transcribed as a longer precursor that needs to be 
further processed before it is biologically active, a process known as RNA maturation.  
Unfortunately, defects arise during RNA transcription and processing, and aberrant RNAs must 
be rapidly degraded and rid from the cell by several different mechanisms collectively known as 
RNA surveillance.  Once correctly processed RNAs perform their cellular functions and reach 
the end of their life-spans, they are degraded during RNA turnover.  The aforementioned 
processes are controlled by either 5’ to 3’ or 3’ to 5’ exoribonucleases.  The 3’ to 5’ RNA 
processing and degradation pathways are completed by the RNA exosome.   
The exosome is a multi-subunit protein complex involved in RNA maturation, surveillance, 
and turnover (1-7).  It degrades RNA starting at the 3’ end of the RNA and degrades the RNA 
until it is completely degraded to 4-5 nucleotide end products in the RNA surveillance and 
turnover pathways, or until it cleaves off the precursor region of the premature RNA in the RNA 
maturation pathway (8-10).  Since the exosome plays an essential role in numerous RNA 
metabolism pathways, it is not surprising that an intact exosome complex is necessary for cell 
viability: deletions of any of the core exosome subunits result in cell death in both yeast (2) and 
humans (11, 12). 
The eukaryotic exosome is a multi-subunit protein complex composed of a nine-subunit core 
that forms a double-layered ring (13).  To degrade RNA, the exosome must associate with 
Rrp44, a 3’ to 5’ hydrolytic exoribonuclease (12, 14).  The exosome is present in both the 
nucleus and the cytoplasm, and functions in different RNA processing pathways in these  
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Figure 1-1. Role of the eukaryotic RNA Exosome.  A) The nuclear exosome is involved in 
the surveillance of aberrantly processed mRNA and tRNA, and the 3’ end maturation of 
snRNA, snoRNA, and rRNA.  The exosome processes some snRNA and snoRNA by use of 
the nuclear specific nuclease Rrp6, which associates with the hexameric RNA binding 
protein Rrp47.  In the nucleus, the TRAMP complex—which contains subunits with 
polyadenylase and helicase activities—helps to prepare substrates for degradation by the 
exosome. B) In the cytoplasm, the exosome is involved in mRNA turnover and surveillance.  
The cytoplasmic exosome associates with the SKI complex, which has a similar function to 
the nuclear TRAMP complex but contains Ski7, a putative ribosomal release factor. 
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different compartments (Fig. 1-1).  In the nucleus (Fig. 1-1A), the exosome is involved in RNA 
surveillance, degrading mRNA precursors that fail any mRNA processing steps such as splicing, 
cleavage, polyadenylation, or export out of the nucleus (7), as well as in the degradation of 
initiator methionine tRNA that is hypomethylated (5).   It is involved in the 3’ end maturation of 
a variety of non-coding RNAs such as small nuclear and small nucleolar (sn and sno) RNA (1, 4) 
(Fig. 1.1A).  It is also involved in some steps of ribosomal RNA maturation, such as the 
degradation of the 3’ end external transcribed spacer (3). 
In the cytoplasm, the exosome is mainly involved in the turnover and surveillance of mRNA 
(Fig. 1-1B).  During turnover, the exosome degrades mRNAs starting from their 3’ end after they 
have first been deadenlyated.  The exosome degrades aberrant mRNAs in a number of 
surveillance pathways.  Surveillance pathways include Nonsense Mediated Decay, where the 
mRNA contains a premature stop codon (15); Non-stop Decay, where the mRNA is missing a 
stop codon (9, 10); and No-Go Decay, where the mRNA contains a strong secondary structure in 
the middle of its sequence that cannot be translated through (16).   
In order to function in some of the aforementioned decay pathways, the exosome associates 
with additional proteins and accessory protein complexes in a compartment specific manner.  In 
the nucleus, the exosome associates with the 3’ to 5’ exoribonuclease Rrp6 (Fig. 1.1A).  Rrp6 
appears to function in snRNA and snoRNA 3’ end maturation, as well as some steps of rRNA 
maturation (17).  Rrp6 also associates with the RNA binding protein Rrp47 in the processing of 
some of these RNA species.  Additionally, the exosome associates with the TRAMP complex 
composed of the polyadenylase Trf4 (or Trf5), the zinc knuckle RNA binding protein Air1 (or 
Air2), and the helicase Mtr4 (Fig. 1A) (18-20).  Trf4/5 polyadenylates RNA on its 3’ end tail, 
which is thought to mark it as a substrate for the exosome, and Mtr4 assists to unwind the RNA 
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before degradation by the exosome (18-20).  Air1 likely binds and positions the RNA while these 
processes occur.   
In the cytoplasm, the exosome associates with the SKI complex formed by Ski2, Ski3, and 
Ski8 (Fig. 1.1B), which appears to play a role similar to the nuclear TRAMP complex, although 
it lacks a polyadenylation subunit (8, 21).  In addition, the SKI complex contains the putative 
GTPase Ski7, which has been shown to bind to the exosome (8-10) and has a similar protein 
sequence as eukaryotic ribosome release factor (eRF3) (22).  Therefore, it is hypothesized that 
Ski7 mimics eRF3 by binding to the ribosome and releasing aberrant mRNA from the ribosome 
to prevent it from being translated (23).  The aberrant mRNA could then be subsequently 
shuttled to the exosome and degraded.  While Ski7 has been implicated in the Non-Stop Decay 
surveillance pathway (9, 10), more research needs to be conducted to prove this hypothesis.  
  
1.2. Structural and Functional Evolution of the Exosome 
 
Exosome like structures are found in all three domains of life.  All exosome like structures are 
composed of a six member ring containing subunits homologous to the bacterial RNase PH (Fig. 
1-2A) (24, 25).  RNase PH is hexameric complex of identical subunits, each of which contains 
phosphoroylytic 3’ to 5’ exoribonuclease activity: a molecule of phosphate is added to the 3’ end 
of the RNA to catalyze degradation of the phosphodiester bond between two nucleotides.  The 
main role of RNase PH appears to be the removal of nucleotides following the 3’ end CCA tail 
of tRNA (26).  Bacteria also contain another 3’ to 5’ phosphoroyltic exoribonuclease that is 
related to RNase PH, but more general in function, called the polynucleotide phosphorylase 
(PNPase).  The PNPase contains three identical subunits.  Each is composed of two central 
RNase PH domains that are attached to C-terminal KH and S1 domains (Fig. 1-2B) (27, 28).  
Though technically a trimer, the presence of dual RNase PH domains (1 and 2) in each of the 
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subunits of the PNPase allows it to fold into a similar hexameric shape as other exosome 
structures.  In the PNPase, only RNase PH Domain 2 is catalytic active; thus, the complex 
contains only three phosphoroyltic active sites.  In addition to its degradation activity, the 
PNPase can also catalyze the reverse reaction by acting as a polyadenosine polymerase to add 
nucleotides onto the 3’ end of RNA.  The PNPase is also present in eukaryotes in both 
chloroplasts and mitochondria, indicating that it retains a compartment specific role in 
eukaryotes (29).  
The archaeal exosome is most similar in structure to the eukaryotic version.  It is similar 
to its bacterial homologues, yet contains a few extra subunits.  The archaeal exosome is 
composed of three heterodimers of RNase PH like subunits Rrp41 and Rrp42 that form a central 
ring, which is capped by three copies of the RNA binding protein Rrp4 or Csl4 (30, 31) to form a 
double layered ring structure (Fig. 1-2C).  Rrp4 and Csl4 contain RNA binding domains similar 
to those found in the PNPase: both Rrp4 and Csl4 contain an S1 domain, and Rrp4 contains an 
additional KH domain.  RNA is channeled through the central ring of the exosome into its active 
site.  A continuous pathway of RNA progression through the channel is indicated by crystal 
structures of archaeal exosomes showing that one nucleotide binds near the opening of the 
channel or the ―neck‖ region, while up to 6 nucleotides bind in the active site formed by subunits 
Rrp41 and Rrp42 (32, 33).  In the active site, Rrp41 serves as the catalytic subunit and degrades 
the RNA using a 3’ to 5’ phosphoroyltic mechanism, while the Rrp42 subunit is inactive.  Thus, 
similar to the PNPase, the archaeal exosome contains three active sites.  Also like the PNPase, 
the archaeal exosome can add polyadenosine to the 3’ end of RNA molecules (30, 32, 34). 
The eukaryotic RNA exosome core features an architecture similar to that of the archaeal 
exosome, but is composed of a wider diversity of subunits that comprise the double layered ring.  
It contains six RNase PH like channel subunits (Rrp41, Rrp45, Rrp42, Rrp43, Mtr3, and Rrp46), 
and three different RNA capping subunits (Rrp4, Rrp40, and Csl4) (2, 13).  As shown by the 
structure of the human exosome (Fig. 1-2D), the eukaryotic exosome has an overall similar 
architecture to the archaeal exosome (13).  Unlike the archaeal exosome, however, the channel of  
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Figure 1-2. Structural Evolution of the exosome.  Structures are viewed on their side (left) and 
in a top to bottom orientation (right).  A) RNase PH from A. aeolicus (pdb 1udn) is composed of 
six identical monomers.  B) PNPase from S. antibioticus (pdb 1e3p) is a homotrimer.  However, 
each subunit contains two RNase PH domains, so the structure mimics the RNase PH structure.  
Monomers contain additional C-terminal KH and S1 RNA binding domains that form loops near 
the entry of the channel.  C) Archaeal exosome from S. solfactaricus (pdb 2jea).  The RNase PH 
ring is composed of three heteordimers of Rrp41 and Rrp42.  The ring is capped with three 
copies of Rrp4 (or Csl4, not shown) which contains RNA binding KH and S1 domains.  
Nucleotides found in the neck and processing chamber of the complex are displayed as spheres, 
and a probably pathway of RNA connecting these two binding sites is represented by a dashed 
line.  D) Eukaryotic exosome from H. sapiens (pdb 2nn6).  The RNase PH ring is formed by 
three heterodimers of Rrp41/Rrp45, Rrp42/Mtr3, and Rrp43/Rrp46.  The RNA capping ring is 
formed by one copy of each of Rrp4, Rrp40, and Csl4.  The figure was created using PYMOL 
software (35). 
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the eukaryotic exosome is catalytically inactive in both yeast (14) and humans (13), a trend that 
is likely conserved among eukaryotes, with some possible exceptions (36).  Instead, activity is 
mainly provided by an additional subunit, the hydrolytic 3’ to 5’ exoribonuclease Rrp44 (also 
known as Dis3) (14).  Rrp44 is a highly processive enzyme and appears to be bound to both 
nuclear and cytoplasmic exosomes in S. cerevisiae (12, 14).  A second hydrolase, Rrp6, is found 
only associated with the nuclear exosome in yeast (12, 37).  All core exosome subunits as well as 
Rrp44 and Rrp6 are conserved to an extent in higher eukaryotes, so the yeast exosome serves as 
a model eukaryotic exosome.  In particular, the main catalytic subunit Rrp44 has been studied 
extensively in this organism.   
 
1.3 Structure and function of the catalytic exosome subunit Rrp44 
 
Rrp44 is composed of an N-terminal endoribonuclease (ENDO) PilT N-terminus (PIN) 
domain connected by a flexible linker to a C-terminal exoribonuclease (EXO) assembly that 
consists of two cold shock domains (CSD1 and CSD2), a large catalytic RNB domain, and a S1 
domain (38) (Fig. 1-3A).  PIN domains from proteins of various archae (39-42), bacteria (43), 
and humans (44, 45) contain a similar α/β/α fold.  Some PIN domains contain endonuclease 
activity (44), but no structure has yet to be solved of a PIN domain bound to RNA.  The structure 
of Rrp44ΔPIN (amino acids 242-1001) catalytically inactive mutant in complex with a single 
stranded polyadenine RNA revealed the topology of the body region of the protein and displayed 
its possible mechanism of RNA degradation (38).  CSD1, CSD2, and S1 consist of a general 
oligosaccharide/oligonucleotide binding (OB) fold, which has five anti-parallel β strands that 
form a β-barrel (46).  The RNB domain is mostly α helical in nature, and has an orientation very 
similar to the same domain in the E. coli exonuclease RNase II (47, 48).  The RNB domain 
contains a channel that is ~10 Å wide, large enough to accommodate only single stranded RNA, 
that is lined with hydrophobic and positively charged residues leading to the active site of the 
protein (Fig. 1-3B-C) (38).  Although the processing channel itself is narrow, its entrance is  
10 
 
 
 
 
 
 
 
Fig. 1-3. Structure of yeast Rrp44.  A) Domain organization of the protein.  B) Structure of S. 
cerevisiae Rrp44ΔPIN with nine polyadenine nucleotides bound in the active site (pdb 2vnu).  
Coloring corresponds to the domain organization depiction above.  RNA is shown in black and 
the magnesium ion is in magenta. C) Cut-away view of the bound RNA with nucleotides labeled 
from the 3’ end (N1) to the 5’ end (N2).  RNA makes most of its contacts in the RNB domain 
channel, and a few contacts with CSD1.  D) Alignment of Rrp44 with E. coli RNase II 
containing bound RNA (pdb 2ix1).  Rrp44 is presented in light shades while RNase II is depicted 
in dark shades.  The bound RNA from the Rrp44 structure is shown as black sticks, while the 
RNA from the RNase II structure is in orange.  Note that the secondary structure of the RNB 
domain is almost identical in the two proteins, but the RNA entry path varies greatly.  This figure 
was created using PYMOL (35).   
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twice as wide and could accommodate duplex RNA.  In the channel, 9 out of 13 nucleotides are 
bound and produce interpretable electron density.  The five 3’ most nucleotides bind in the 
catalytic center by means of electrostatic and base-stacking interactions with channel residues, 
and the nucleotides are threaded into the channel by binding between the CSD1 and RNB 
domains (38).   
The complex structure of Rrp44 bound to a single stranded RNA substrate indicates that 
the RNA makes most of its contacts within this channel, with a few additional contacts to CSD1 
near the entrance to the channel (Fig. 1-3C).  Although this structure provides insight into how 
RNA binds in the RNB channel, the exact mechanism of RNA recruitment is still unclear.  The 
structure is almost identical in domain organization to that of E. coli RNase II (which lacks a PIN 
domain), but RNase II directs the RNA towards its channel through contacts in the CSD2 and S1 
domains instead (47, 48), which have yet to be implicated in RNA binding in Rrp44 (Fig 1-3D).  
Thus, it is unclear whether this different pathway represents divergent evolution of the two 
enzymes or whether the RNA binding site in the structure of Rrp44 is an artifact introduced by 
crystal lattice packing.  If the RNA recruitment pathway proposed from the crystal structure is 
physiologically relevant, it does not appear that it functions in concert with the exosome in its 
crystallized form, since the 5’ end of the RNA is pointed towards the solvent.  Association of 
Rrp44 with the exosome, however, could result in a conformational change that would place the 
RNA entry site in line with the exit site of the exosome channel.     
The EXO active site is located at the end of the channel in the RNB domain (38) and is 
used by Rrp44 to processively degrade one nucleotide at a time starting at the 3’ end of the RNA.   
The active site contains density for one of two proposed magnesium ions, predicted to be 
involved in a two metal ion catalytic mechanism of degradation by Rrp44.  The bound metal ion 
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is coordinated by D543, D552, and O3’ of the phosphate from the second nucleotide, and the 
absent but proposed second magnesium ion is predicted to be coordinated by D549 and D551 
(38).  Since the D551N mutation inhibits exonuclease activity, it is likely that this mutation 
prevents coordination of the second magnesium ion, which results in its absence from the 
structure.  The second metal ion is predicted to stabilize an activated water molecule and position 
it for attack on the scissile phosphate of the nucleotide at the 3’ most end of the RNA (47).  A 
particularly interesting facet of Rrp44 is its ability to process duplex RNA.  The channel is only 
wide enough to accommodate single stranded RNA, yet Rrp44 can also degrade RNA duplexes 
with a long 3’ overhang (38).  The PIN domain of Rrp44 appears to be implicated in RNA 
unwinding by an unknown mechanism because Rrp44ΔPIN degrades duplexes with a short 
overhang much less efficiently than the full length version (38).  The mechanism of RNA 
unwinding by Rrp44 is not fully understood because unlike RNA helicases, no ATP hydrolysis is 
involved to provide the energy required for unwinding.  It is also not clear how this unwinding 
ability would function when Rrp44 is bound to the exosome core.   
An ENDO active site resides in the PIN domain of Rrp44, which appears to be active on 
single stranded regions of RNA (49-51).  While yeast cells that contain a mutation in either the 
EXO (D551N) or the ENDO (D171N) site are viable, mutation of both sites results in lethality 
(49-51).  Interestingly, the two sites are optimally active at very different concentrations of metal 
ions.  The EXO site is most active at low concentrations of Mg
2+
 (~100 uM) as indicated by in 
vitro studies, and inactive in high Mg
2+
 (5 mM) (14), while the ENDO site is active at high levels 
of Mn
2+
 (~3 mM) (49-51).  It is a bit peculiar that the manganese concentration is much higher 
than physiological concentrations in cells.  However, yeast genetic experiments indicate that both 
activities are used in vivo.  It was reported that either active site can be used by Rrp44 to degrade 
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nonstop decay transcripts in vivo, yet degradation of normal mRNA during turnover was 
impeded by a mutation in only the exonuclease active site (52), and defects in 5.8S rRNA and 
snoRNA processing only occur as well with this mutation (49-51) .  It has also been suggested 
that the PIN domain may assist in EXO mediated RNA unwinding (38).  Likely, the PIN domain 
serves as an additional RNA binding platform that supports the substrate during degradation or 
directs it into the exonuclease active site of Rrp44.  It is also possible that the two active sites 
work together to degrade certain substrates and a popular hypothesis is that the ENDO site 
creates new 3’ ends on RNA substrates that are then degraded by the EXO site of Rrp44.    An in 
vitro experiment supported this hypothesis by indicating that the endonuclease activity of Rrp44 
cleaved single stranded loops in the 5’ external transcribed spacer (5’ ETS), a long excised 
region that is produced during rRNA maturation (49).  However, since the two active sites are 
spatially distant, any synergy between them would need to be preceded by a conformational 
change in Rrp44 to bring the two sites into closer proximity, or would occur by the EXO and 
ENDO sites degrading different regions of the substrate either simultaneously or sequentially.  
Moreover, the mechanism of how the two sites would work together when Rrp44 is bound to the 
exosome is not yet known.   
 
1.4. Association of Rrp44 with the Exosome Core 
  
Given that the eukaryotic core exosome is inactive and that Rrp44 appears to achieve the 
catalytic activity for the complex, it is curious what the actual role of the exosome core is, and 
how it is involved in Rrp44 mediated RNA degradation.  A negative stain EM reconstruction by 
Hongwei Wang in collaboration with the Ke group first revealed the architecture of the yeast  
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Figure 1-4. EM reconstruction of the yeast exosome and possible pathways of RNA 
recruitment.  A) Reconstruction of the Rrp44 bound exosome (gray envelope, EM Databank ID 
1438) with the crystal structure of the human exosome (pdb 2nn6) and yeast Rrp44ΔPIN (pdb 
2vnu) docked in.  Bound RNA is shown in black sticks.  Docking was completed with UCSF 
Chimera (54).  Note that the N-terminal PIN domain and the C-terminal catalytic region of 
Rrp44 appear to be located 20 Å apart.  B) Possible ―Through Exosome Route‖ reminiscent of 
the archaeal exosome.  Note that the RNA could potentially interact with either the exo- or endo- 
nuclease sites after exosome channeling.  C) The ―Direct Access‖ exonuclease degradation 
pathway, in which the RNA would access the exonuclease site of Rrp44 in a manner similar to 
that in RNase II.  D) ―Direct Access‖ endonuclease pathway.  This route could possibly be used 
to feed shortened RNAs into the exonuclease site during the degradation of more structured 
RNA.  
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exosome core and the yeast Rrp44 bound exosome (53).  The exosome core reconstruction 
revealed a general ring and channel shape, and all subunits of the crystal structure of the human 
exosome could be docked into the reconstruction with a good fit, with the exception of Csl4, 
which appeared substoiciometric during purification.   
The Rrp44 bound exosome reconstruction contained a ring structure in a similar 
conformation as that of the exosome core, but the large, two lobed density of ~140,000 Å
3 
was 
attached to the bottom of the ring, corresponding to the 114 kDa Rrp44 protein (Fig. 1-4A) (53).  
About three-fourths of the density (~85 kDa) corresponded to the C-terminal region (―the body‖)  
of Rrp44, while the rest of the density (~28 kDa) resulted from the N-terminal PIN domain 
region (―the head‖) of Rrp44.  The head and body regions of Rrp44 were separated by a distance 
of about 20 Å, and were connected by a flexible linker barely interpretable in the density.  Upon 
analysis of the EM reconstruction, the head region of Rrp44 was determined to be a major site of 
the attachment of Rrp44 to the exosome, since this region buried a large surface area of 1,000 Å
2
 
into the exosome core subunit Rrp41.  The body region of Rrp44 made most of its contacts to the 
exosome core through the Rrp45 subunit, burying a surface area of 1,800 Å
2 
(53).  A secondary 
contact was also established between the body of Rrp44 and the subunit Rrp43, burying a smaller 
surface area of 400 Å
2
.  Thus, Rrp44 appears to bind mainly to subunits Rrp41 and Rrp45 and is 
bound on the bottom side of the exosome core, situated underneath the channel.   
Since Rrp44 is located on the exosome opposite the RNA binding cap and below the exit 
site of the channel, this places it in a position to receive RNA that is first funneled through the 
channel.  The RNA could then pass into the exonuclease active site of Rrp44 for degradation, 
mimicking a mechanism similar to that of the archaeal exosome (Fig. 1-4B).  Alternatively, the 
RNA could also potentially access the endonuclease site after exosome channeling, although this 
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may require a conformation change in Rrp44 since the PIN domain is mostly solvent exposed.  A 
more recent Cryo-EM reconstruction of the Rrp44 bound exosome bound to a predominately 
single stranded RNA revealed extra electron density for RNA within the channel, yet the RNA 
was featureless and appeared loosely bound so it was not possible to clearly determine how it 
interacted with the channel (55).  Rrp44 could also directly access the RNA substrate by means 
of either the solvent exposed pathway to its exonuclease site that was shown in the crystal 
structure (Fig. 1-4C), or its endonuclease PIN domain (Fig. 1-4D).  The later pathway could 
potentially generate small RNA fragments that would then be feed into the exonuclease site for 
complete degradation.  This pathway could be used by the exosome when degrading structured 
RNA, but its existence remains elusive.  
 
1.5. Role of Rrp6 and nuclear associated proteins in exosome mediated degradation 
 
Rrp6 is 3’ to 5’ distributive hydrolytic exoribonuclease found in the nuclear exosome in S. 
cerevisiae that plays a prominent role in trimming snRNA, snoRNA, and portions of rRNA 
species into their mature forms (56-58).  It contains an N-terminal domain that is predicted to be 
disordered, an exonuclease domain, a helicase and RNase D carboxy terminal (HDRC) domain, 
and a longer C-termius that is predicted to be unstructured (Fig. 1-5A).  Crystal structures of the 
catalytic region of Rrp6 from yeast (amino acids 129-536, Fig. 1-5B) (59) and human (60) reveal 
a structure similar to that of RNase D (61) (Fig. 1-5C).  However, RNase D includes an 
additional HDRC domain, has a shorter N-terminus, and lacks a disordered C-terminus.  Rrp6 
and RNase D are members of the DEDD family of RNA and DNA exonucleases, which contain 
nucleases such as RNase T (62) and the Klenow fragment of DNA polymerase I (63).  Members 
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of this family use the DEDD residues to coordinate metal ions, which deprotonate a water 
molecule, creating a nucleophile that attacks the phosphodiester backbone of the RNA substrate 
(64).  Specifically, RNase D and Rrp6 are part of a subset of DEDDy proteins that contain an 
additional tyrosine that coordinates the nucleophilic water.  The distributive activity of Rrp6 is 
explained by the fact that its active is on the surface of the protein (59), preventing sequestering 
of the substrate which allows for processive degradation in Rrp44.  Moreover, functional studies 
indicate that Rrp6 stalls upon encountering RNA stem loops (13, 60), suggesting its role in 3’ 
end trimming but not complete degradation. 
Although Rrp44 is an integral member of the exosome in yeast, the association of Rrp6 
with the exosome and its role in RNA degradation is less clear.  Pull-down assays indicated that 
the N-terminus of Rrp6 is required for binding to the exosome (65), but it is not known with 
which subunits it interacts in yeast.  However, yeast two hybrid experiments conducted with 
human proteins indicated that Rrp6 interacts with Rrp41, Rrp43, Rrp46, and Mtr3, yet the 
location of Rrp6 on the exosome is unknown (66).  Rrp6 is assumed to be positioned on the top 
of the exosome ring distal to Rrp44, and near or bound to the RNA cap, based on a negative stain 
EM structure of the Leishmania tarentolae exosome (67).  However, the rather poor resolution of 
the reconstruction prevents unambiguous assignment of the Rrp6 binding site and its orientation, 
and it is unknown whether such an association is conserved in higher eukaryotes.  A current 
mechanistic model indicates that Rrp6 processes structured RNA that does not enter the exosome 
channel, yet this hypothesis does not explain why it needs to be attached to the exosome to 
perform these processes.  Also, despite its role in maturation of RNA, deletion of Rrp6 from S. 
cerevisiae does not result in lethality (17), which results by deleting any of the other exosome 
subunits (2).  Moreover, functional exosomes can be isolated from Rrp6Δ yeast strains,  
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Figure 1-5. Structure of the catalytic region of yeast Rrp6.  A) Domain organization of S. 
cerevisiae Rrp6.  The numbering scheme corresponds to the amino acid length.  Domains not 
found in the crystallized fragment are colored in white.  B) Structure of the catalytic region 
(amino acids 129 – 536) of yeast Rrp6 bound to metal ions and UMP (pdb 2hbm).  Domain 
coloring corresponds to the diagram above.  Bound UMP is colored in black.  A zinc ion near the 
active site is in grey and a manganese ion is in lime.  C) Alignment of S. cerevisiae Rrp6 
catalytic region (dark blue, pdb 2hbm) with the catalytic region of human Rrp6 (light green, pdb 
3SAH) and E. coli RNase D (yellow, pdb 1YT3).  The additional HDRC domain in RNase D is 
boxed.   Figures B and C were created with PYMOL software (35).    
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suggesting that it is not necessary for the structural integrity of the exosome.  Thus, it is possible 
that Rrp44 can compensate for some of the functions of Rrp6.  
 Another protein which plays a key role in nuclear exosome processing is Rrp47.  Rrp47 is 
a basic protein that binds to the N-terminal PMC2NT domain of Rrp6, and it appears to function 
in the processing of snRNA and snoRNA, since deletion of Rrp47 results an accumulation of  
precursor RNAs which are similar to those occurring in Rrp6 deletion strains (56-58).  Rrp47 
possess no catalytic activity but forms a hexamer in vitro that can bind tightly to structured RNA 
and Rrp6 simultaneously (57, 58); interestingly, Rrp47 also binds double stranded DNA (57).  It 
is hypothesized that hexamerization of Rrp47 may thus create an RNA binding channel that 
deposits the substrate into the active site of Rrp6, although no structural studies have yet to 
confirm this assumption.  It appears that one function of Rrp47 is to bind to small nucleolar 
ribonucleoprotein (snoRNP) complexes to guide the processing of the 3’ tails of C/D box 
snoRNAs—which are involved in rRNA methylation—by Rrp6 (58).  Theories speculate that 
Rrp47 may serve as either an RNA binding platform for Rrp6 or to help regulate its activity.  A 
second protein known as Mpp6 also associates with Rrp6 (68, 69), and may serve a similar role 
as Rrp47.  It is likely that each protein is specific for certain substrates. 
 
1.6 The role of Ski7 in cytoplasmic mRNA decay 
 
Ski7 stably associates with the cytoplasmic exosome and is retained during TAP purifications of 
the complex.  Ski7 has been suggested to bridge interactions between the exosome and the SKI 
complex during cytoplasmic exosome mediated degradation (23).  The N-terminus of Ski7 is 
required for proper degradation of normal mRNAs, while its C-terminus is dispensable for this 
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function (70).  Ski7 has also been implicated in the non-stop decay RNA surveillance pathway, 
where transcripts lacking a stop codon are rapidly degraded by the exosome, beginning with their 
3’ polyadenine tail (9, 10).  Separate N-terminal portions of Ski7 bind to both the exosome and 
the Ski complex (Fig. 1-6A), and Ski7 is hypothesized to tether the complexes together to allow 
RNA to be unwound by Ski2 before being degraded by the exosome (70, 71).  Ski7 is thought to 
bind to the cap proteins of the exosome since it co-purifies with Csl4 and Rrp4 (9), however, 
definitive experiments have yet to be completed to prove this hypothesis.  In particular, the zinc-
ribbon domain of Csl4 may serve as a primary binding site since it is essential for mRNA decay, 
but not decay of other species of RNA (50). 
  Although no structural information exists for Ski7, it is predicted to have GTPase 
activity based on the similarity of its C-terminal region (Ski7-c) to structures of elongation factor 
1A (EF1A) and eukaryotic release factor 3 (eRF3).  Crystal structures of EF1A from S. 
cerevisiae (Fig. 1-6B) (72-74) and the C-terminal region of eRF3 (eRF3-c) from S. pombe (Fig. 
1-6C) (75) have a similar architecture.  Both structures have a Domain 1 that contains a GKT/S 
P-loop that coordinates an Mg
2+
 ion (73), and binds the phosphate moiety of GTP/GDP as well 
as an NKxD motiff that binds the nucleotide ring of guanine.  Domain 1 also contains the Switch 
I and Switch II helices that are responsible for the exchange of GTP for GDP (72, 75).  Although 
the GTP/GDP binding sequence motifs are conserved in Ski7-c, the rest of Ski7-c does not align 
well with EF1A or eRF3 and contains several insertions (76).  Furthermore, these regions are 
common to GTPases and do not necessarily suggest a function conserved beyond basic GTP 
hydrolysis. For instance, although eEF1A and eRF3c have a similar architecture, they have 
disparate roles in translation.  During elongation, EF1A binds GTP and brings aminoacylated 
tRNA (aatRNA) (77) to the A site of the 80S ribosome, where the aatRNA binds to its specific 
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codon of the translating mRNA.  On the other hand, eRF3 functions during termination by 
mimicking the structure of a tRNA to and recognizes all three stop codons (78).  The GTPase 
activity of eRF3 is stimulated by binding to release factor 1 (eRF1) and the ribosome, and GTP 
hydrolysis drives peptide release from the ribosome.   
Given some sequence similarity between eRF3 and Ski7 and its necessity in Non-Stop 
decay, it is an intriguing hypothesis that Ski7 is involved in peptide release in a stop codon 
independent manner.  Stop codon independent termination of structured mRNA does occur in the 
No-Go pathway and requires Hbs1 and Dom34, eRF3 and eRF1 paralogues, respectively (16), 
which appear to function in a similar manner to cause peptide release.  If Ski7 functioned in a 
similar manner, it would be expected to bind to a protein resembling eRF1 to cause polypeptide 
release, but no such binding partner has been identified.  It is also possible that Sk7 has no direct 
role in termination but instead serves mainly as an adaptor to bring the exosome to the ribosome 
to allow for rapid degradation of mRNA after termination has occurred.  A thorough 
investigation of the biochemical properties of Ski7 and its relation to the exosome must be 
conducted to clarify its role in Non-Stop decay. 
 
1.7. Conservation of the exosome in eukaryotes 
 
The exosome has been studied extensively in budding yeast and more recently in humans, and 
the core exosome appears to be for the most part conserved between these two species.  One 
main exception is that subunit Rrp45 contains a long C-terminal extension in humans (13) that is 
absent in the S. cerevisiae exosome.  This region wraps around the solvent exposed surface of 
subunits Rrp46 and Rrp43 (13), and could possibly provide additional crystal contacts that 
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Figure 1-6. Binding region of Ski7 and possible structural homology.  A) Schematic diagram 
of amino acid regions of Ski7 shown to bind to the SKI complex (lavender) and the exosome 
(tan), as well as the region homologous to EF1A and eRF3 (light blue).  The amino acid number 
is given above the diagram.  B) Crystal structure of the C-terminal region of S. pombe eRF3 (pdb 
1r5b).  C) Crystal structure of the S. cerevisiae EF1A (modified from the EF1A/EF1Bα complex, 
pdb 1f60).  Figures B and C were created using PYMOL software (35).    
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allowed the human exosome to crystallize, while the yeast version is thus far recalcitrant to 
crystallization.  Regardless, deleting this region from the crystal structure and docking the human 
exosome into the yeast exosome EM envelope results in a good fit (Fig. 1-4A), indicating that 
the yeast core exosome likely forms a similar structure.   
While the core exosome subunits appear to be consistent in yeast and humans, some 
differences appear to occur in other eukaryotes.  A few organisms lack particular subunits; for 
instance D. melanogaster exosomes lack subunit Rrp43.  While the exosome core is inactive in 
yeast and humans, A. thaliana Rrp4 contains phosphoroyltic RNase activity (79) and rice Rrp46 
forms a homodimer and contains both phoshoroyltic RNase and hydrolytic DNase activity (80).  
Therefore, it appears that in some eukaryotes the structure and function of the exosome has 
diverged.  
The association of higher eukaryotic exosomes with Rrp44 differs between yeast and 
humans.  While the yeast exosome binds tightly to Rrp44 during Tandem Affinity Purifications 
(TAP), Rrp44 was initially not retained in human exosome purifications (81), due to salt 
sensitive dissociation of Rrp44.  The association of human Rrp44 with the exosome is also 
complicated by the fact that higher eukaryotes such as humans, mice, and frogs contain genes for 
three Rrp44 like proteins known as (using the alternative Dis3 nomenclature) hDis3, hDis3-like 
exonuclease 1 (hDis3L1), and hDis-3 like exonuclease 2 (hDis3L2).  Both hDis3 and hDis3L1 
contain regions predicted to form PIN domains, and thus could potentially interact with the 
exosome, while hDis3L2 has no PIN domain and likely does not interact with the exosome.  
Subsequent TAP purifications conducted in the presence of a low NaCl concentrations reveal 
that both hDis3 and hDis3L1 do associate with the exosome (82, 83).  While both isoforms 
display exonuclease activity and contain a structural PIN domain (82, 83), only hDis3 has 
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endonuclease activity, (82) and can complement Dis3 depleted yeast cells yet hDis3L1 cannot.  
Furthermore, the two isoforms localize to different cellular compartments in humans.  While 
hDid3 localizes to the cytoplasm and the nucleus (specifically the nucleoplasm), hDis3L1 is 
restricted to the cytoplasm (82).  Although hDis3L2 lacks a PIN domain and presumably does 
not bind to the exosome or possess endonuclease activity, it is an active exonuclease and 
localizes to the cytoplasm (84).  Therefore, the pattern of Rrp44-mediated exosome degradation 
appears more complex in human as opposed to yeast cells.  Current information indicates that 
each Rrp44 isoform could have a compartment specific role in humans. 
The human exosome also contains an analogue of Rrp6 known as PM-SCL-100 or hRrp6 
that is known to be involved in nuclear RNA processing.  Unlike in the yeast exosome, however, 
hRrp6 has been reported to localize to both the nucleus and cytoplasm (11, 15).  Structural 
comparison between the catalytic domains of the yeast and human Rrp6 indicate that the human 
version has a more exposed active site (Fig. 1-5C), and RNase assays indicate that this provides 
it with a greater ability to degrade structured RNA (60).  Similar to the yeast exosome, hRrp6 is 
known to associate with human Rrp47 (C1D), and also human Mpp6 (MPHOSPH6) (85).  
Furthermore, it associates with the human nuclear exosome targeting (NEXT) complex 
composed of members of the TRAMP complex such as hMtr4, the zinc knuckle protein 
ZCCHC7 (an Air2 homologue), and hTrf4-2 (a Trf4 homologue) (86).  Likely, compartment 
specific proteins allow for a different selection of RNA substrates in different compartments. 
In contrast to Rrp44 and Rrp6, Ski7 has not been identified in humans.  Although a 
putative Ski7 homology protein has been identified in Schizosacchromycces pombe, in general 
Ski7 is poorly conserved even within yeast species (76).  Therefore, either functional—but not 
necessarily structural—homologues of Ski7 have yet to be identified in other species, or Ski7 is 
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restricted to a small class of yeast species. 
 
1.8. Role of the exosome in human pathologies 
 
Subunits of the human exosome were initially identified to be involved in human pathologies 
well before their role in RNA degradation was known.  The human exosome is a well-established 
target of autoimmunity in the connective tissue disease polymyositis/scleroderma-overlap 
syndrome (PM/SCL) (87-90), and in fact this is the origin of the alternative names of several 
human subunits such as Rrp6 (PM-SCI-100) and Rrp45 (PM-SCL-75).  PM/SCL is an 
autoimmune disorder: autoantibodies target a patient’s own proteins, destroying their function.  It 
is characterized by weakening of the muscles, impairing the patient’s normal mechanical ability.  
In PM/SCL, autoantibodies frequently target hRrp4, hRrp6, hRrp45, and hRrp47, which are 
listed in the order of decreasing percentage of occurrence of autoantibodies found in the patient’s 
serum (91).  It is therefore likely that PM/SCL results from impaired RNA metabolism that 
results from the targeted destruction of exosome subunits.  However, despite the advances made 
in exosome research over the past decade, little evidence exists as to why the exosome is targeted 
in PM/SCL or how this targeting results in muscle deterioration.  A better mechanistic 
understanding of the exosome may thus shed insight into the molecular consequences of the 
disease on patients and possible ways to overcome them. 
The exosome has also been implicated in cancer.  Auto-antibodies attack the exosome 
subunit hRrp46 in patients suffering from chronic myelogenous leukemia (92), a cancer that 
causes the uncontrolled production of myeloid cells and represents about 20% of all adult 
leukemias (93).  Although hRrp46 is the only subunit yet implicated in this disease, more 
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comprehensive studies may implicate other subunits as well.  The exosome is also a secondary 
target of the chemotherapy drug 5-fluorouracil, which is used to treat colorectal and pancreatic 
cancers.  Although the main target of this pyrimidine analogue is thymidylate synthase—
resulting in inhibited thymine production—it has been found to inhibit the nuclease activity of 
Rrp6 in both yeast (94) and humans (95).  Treatment with the drug results in the accumulation of 
precursor rRNA due to the inhibited processing ability of Rrp6 (94).  Thus, Rrp6 could serve as a 
possible target of new cancer therapeutics.  
Although the exosome is the target of autoimmune disease, it is essentially involved in 
protecting organisms from genetic and possibly pathogenic damage by degrading nonsense 
transcripts which cause about one third of all inherited human diseases.  Further characterization 
of the role of the exosome in human nonsense mediated decay may thus be useful for 
determining how some nonsense transcripts fail to be degraded and are translated into aberrant 
proteins that cause disease.   
 
1.9. Conclusions and areas of future study 
 
 Over the last thirteen years, a wealth of research has been conducted to characterize the 
structure and functional roles of the exosome.  Structures of exosome like complexes have been 
determined in all three domains of life and maintain a similar multi-subunit ring.  In particular, 
the crystal structure of the human exosome revealed how eukaryotic exosomes are composed.  
Despite the reoccurrence of the exosome core like structures throughout evolution, a key finding 
revealed that the eurkaryotic exosome core is inactive in most eukaryotes, except when 
associated with either Rrp44 or Rrp6 nucleases.  Work on these two nucleases has provided us 
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with structures of the catalytic regions of both of them, as well as likely mechanisms of how they 
function to degrade RNA.  Moreover, recent work has indicated how the human versions of these 
enzymes relate to their more studied yeast counterparts.  Specifically, three isoforms of Rrp44 
exist in human cells, but only two associate with the exosome, and human Rrp6 has a structure 
similar to yeast but has a more open active site to allow for less restricted RNA access.  These 
findings provide us with a clearer understanding of how the exosome functions during RNA 
degradation. 
The fact that the core exosome itself is inactive in eukaryotes, however, remains a 
curiosity.  It is interesting to ponder whether the exosome core retains a functional role, or 
instead serves mainly as a scaffold for the attachment of nuclease subunits.  While the location of 
where Rrp6 binds to the core has yet to be determined, it is generally accepted that Rrp6 
degrades RNA without making use of the exosome channel, and it has even been suggested that 
it can function in a similar manner without even binding to the exosome (65).  In contrast, EM 
reconstructions of the Rrp44 bound exosome clearly place Rrp44 on the underside of exosome 
channel (53, 55).  While the eukaryotic core exosome has been suggested to function in a manner 
similar to its archaeal cousin during Rrp44 mediated RNA degradation, it largely remains to be 
determined whether RNA can access Rrp44 without being first being channeled through the core.  
This is an intriguing hypothesis, given that Rrp44 contains endonuclease activity in its PIN 
domain, a region that appears inaccessible to RNA traveling through the exosome core (53). 
The main goals of our work are to more holistically characterize the structure of the 
eukaryotic exosome and the process of how it degrades RNA.  We begin with structural and 
functional studies of the Rrp44 bound exosome, with a goal of testing the possibility of the 
―direct access‖ pathway of RNA recruitment to Rrp44.  We characterize the association of the 
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nuclear exosome with Rrp6, Rrp47, and various other nuclear cofactors in attempts of obtaining 
detailed information on the structural associations of these proteins with the exosome.  The work 
presented here as well as continued studies will help to define the possibly mechanisms of RNA 
processing by the eukaryotic exosomes.       
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Chapter 2: Structural Studies of the Association of Rrp44 with the Exosome Core 
Abstract 
This chapter details efforts towards obtaining high resolution structural information on the 
association of Rrp44 with the eukaryotic exosome.  It was determined that the N-terminal region 
of Rrp44 (amino acids 1-270) was necessary and sufficient for binding to exosome subunits 
Rrp41 and Rrp45.  A ternary complex between Rrp41/Rrp45 and Rrp44 1-270 was then 
crystallized, but poor diffraction impeded structural determination.  Other truncations of the N-
terminal region of Rrp44 were attempted for crystallization in complex with Rrp41 and Rrp45, as 
well as Rrp44 homologues from other organisms, but crystals were not obtained.  While our 
efforts were in progress, another group determined a structure of the full length 
Rrp44/Rrp41/Rrp45 ternary complex.  Although this complex is helpful in elucidating how 
Rrp44 binds to two subunits of the exosome, it does not dock well into the EM reconstruction of 
the yeast Rrp44 bound exosome.  Moreover, the structure indicated that the RNA binding 
channel of Rrp44 was blocked when bound to Rrp41/45, suggesting a mechanism of regulation 
of Rrp44 by the exosome.  However, we solved the structure of the Apo Rrp44ΔPIN (amino 
acids 242-1001) and showed that the RNA binding channel is blocked in this structure as well, 
indicating that RNA binding causes a conformational change to open up the site, and that 
exosome binding is not involved.  Overall, it appears that RNA could still potentially directly 
access Rrp44 without prior channeling through the exosome core, and that further studies are 
needed to determine the exact mode of interaction between Rrp44 and the complete exosome 
core during RNA degradation. 
 
2.1. Introduction 
 
In order to thoroughly understand the mechanism of RNA recruitment and processing by the 
eukaryotic exosome, it is critical to elucidate how Rrp44 binds to the exosome core.  Although 
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the structure of the human core exosome has been solved (1), the human Rrp44 bound exosome 
would be a difficult structural target to pursue.  At the time of the beginning of our experiments, 
the human Rrp44 was not known to associate with the human exosome core (2) yet later reports 
indicated that an association did exist (3, 4).  The association of the human core exosome with 
Rrp44 is a more complex matter since three main version of Rrp44 are present in human cells 
(hDis3, hDis3L, and hDis3L2), as well as several potential isoform variants created by 
alternative splicing events (3).  The human exosome has been shown to associate with a least two 
of the three known Rrp44 like proteins in human, hDis3 and hDis3L, (3, 4) yet the association 
appears to be relative weak, to the extent that it was hidden by previous experiments that used 
more stringent wash conditions (2).  Due to the inherent difficulties of a human Rrp44 bound 
exosome, our studies focused mostly on the yeast exosome.   
The yeast exosome associates tightly to Rrp44 (5), and the stable complex can be isolated 
using the TAP procedure, as demonstrated by the Ke group (6) as well as others (7), making it a 
better target to study the Rrp44-exosome association than the human exosome.   Despite the fact 
that Rrp44 forms a stable complex with Rrp44, no crystal structures of the Rrp44 bound exosome 
have been forthcoming.  The EM reconstruction of the yeast Rrp44 bound exosome by Hongwei 
Wang and the Ke group provided the first glimpse of the association of Rrp44 to the exosome 
core, and indicated a strong interaction of the N-terminal PIN domain of Rrp44 to the core 
subunits Rrp41 and Rrp45 (6).  In order to more clearly understand this interaction, a higher 
resolution crystal structure of the Rrp44/Rrp45/Rrp41 sub-complex was needed.  The EM 
reconstruction of the yeast Rrp44 bound exosome, as well as sequence conservation alignments 
were used to predict that a minimal region of Rrp44, amino acids 1-270 (hereby referred to as 
Rrp44ΔC), should be sufficient to bind to subunits Rrp41 and Rrp45, which was then confirmed 
by biochemical experiments.  Our early efforts were focused on crystallizing the 
Rrp44ΔC/Rrp41/Rrp45 sub-complex.       
 
2.2. Crystallization of an Rrp41/Rrp45/Rrp44 Head Ternary Complex 
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2.2.1. Methods 
 
Plasmid Preparation 
The coding regions of S. cerevisiae genes were PCR amplified from genomic DNA using Iproof 
high fidelity DNA polymerase enzyme (BioRad).  A polycistronic plasmid containing the genes 
Rrp41, Rrp45, and Rrp46 was created using overlap extension PCR (8), ligated into a 
pACYC184 vector containing a hexahistidine tag with a Tobacco Etch Virus Cleavage site, and 
tetracycline selection marker.  The Rrp44 C-terminal deletion (ΔC, amino acids 1-270) was 
cloned using ligation independent cloning (LIC) (9) into a pLIC vector containing an N-terminal 
hexahistidine tag, a Tobacco Etch Virus Cleavage site, and a kanamycin selection marker.  
Plasmids were transformed into DH5α competent cells and grown on the kanamycin or 
tetracycline selective plates.  DNA from single colonies was purified and all plasmids were 
sequenced to confirm the presence of the correct insert.   
Protein Expression and Purification 
For expression, plasmids were cloned into E. coli BL21* cells.  Volumes of 3 – 4.5 L of 
antibiotic supplemented LB were inoculated with culture, grown at 37°C and 200 rpm to OD600 
of 1.5 - 1.75, and induced with 1 mM IPTG at 18°C and 200 rpm overnight.  Cell pellets were 
resuspended in Buffer A (20 mM Tris pH 7.5, 300 mM NaCl, 5 mM Imidazole, 5 mM 
betamercaptoethanol, 10% glycerol, and 1 mM PMSF) and were lysed by sonication.  After 
centrifugation to pellet cell debris, supernatant was applied to Ni-NTA resin.  The column was 
then washed with 10 column volumes of Buffer A containing 10 mM imidazole, and eluted with 
Buffer A supplemented with 300 mM Imidazole.   
Complex Formation and Crystallization 
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After Ni-NTA purification, the Rrp44ΔC and the Rrp41/Rrp45 complex (Rrp46 is untagged and 
thus is absence from the complex) were then purified separately on a MonoQ column (GE 
Healthcare) in 20 mM Tris pH 7.5, 5 mM betamercaptoethanol, and 10% glycerol, and eluted 
using an increasing gradient of NaCl.  The Rrp41/45 sub-complex and Rrp44 1-270 were ~90% 
pure as judged by SDS-PAGE analysis and Coomassie Blue staining (Fig. 2-1A-B).  Protein 
concentrations were quantified by Bradford assay (10, 11).   
For complex formation, Rrp41/45 and Rrp44ΔC were incubated in a 1:1.5 molar ratio in 
20 mM Tris pH 7.5, 5 mM betamercaptoethanol, and 10% glycerol and purified on a MonoQ 
column, and peak fractions were analyzed.  The ternary complex contained stoichiometric 
amounts of Rrp41, Rrp45, and Rrp44ΔC as judged by SDS-PAGE with Coomasie Blue staining, 
and was at least 95% pure (Fig.2-1C).  Fractions containing the complex were pooled and 
concentrated to ~10 mg/mL for crystallization.  Manual screening was completed using Hampton 
Screen I and II kits by mixing 1 µL of protein with 1 µL of well solution, and incubating at room 
temperature over a reservoir solution of 500 µL in large well hanging drop vapor diffusion trays.  
Initially, crystal showers appeared in 100 mM HEPES sodium, 20% PEG 4000, and 10% 
isopropanol (Fig.2-2A).  After optimization and streak seeding, small, needle crystals of 
dimensions of about 5x5x50 m3 were produced in the final conditions of 100 mM HEPES 
sodium, 16.5% PEG 4000, and 10% isopropanol (Fig.2-2B). 
 
2.2.2. Results 
 Crystals were tested for diffraction ability at the Advanced Photon Source at Argonne  
National Laboratory.  In general, the crystals diffracted rather poorly, and at best a few 
diffraction spots were observed at ~ 5.5 Å (Fig. 2-2C).  Thus, the diffraction was not of sufficient  
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Figure 2-1. SDS-PAGE analysis of Rrp41/45 and Rrp44 1-270.  Proteins were purified by Ni-
NTA chromatography followed by a MonoQ column, and peak fractions were analyzed on 10% 
polyacrylamide gels.  A) The Rrp41 and Rrp45 sub-complex. B) Rrp44 amino acids 1-270, 
containing minor impurities.  C) After incubating the Rrp41/45 sub-complex with Rrp44 1-270 
and separating the mixture through a MonoQ column, the pure ternary complex elutes out in a 
single peak, followed by excess Rrp44 (not shown).  BL is the before column loading sample, 
and M is the molecular weight marker. 
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Figure 2.-2. Crystallization of the Rrp41/45/Rrp44ΔC ternary complex and diffraction 
analysis.  A) Initial crystal showers were produced at a protein concentration of 10 mg/mL and 
mixing protein in a 1:1 ratio with crystallization solution containing 100 mM HEPES sodium pH 
7.5, 16 – 20% PEG 4000, and 8-10% isopropanol in a hanging drop crystallization tray.  B) 
Streak seeding the crystal showers into optimized conditions of 16.5% PEG 4000 and 10% 
isopropanol produced small needle crystals.  The image shows crystals viewed under polarized 
light.  C) Diffraction analysis of optimized crystals taken at the Advanced Photon Source at 
Argonne National Laboratory.  Diffraction was insufficient for structural determination. 
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quality to collect a data set for structural determination. 
 
2.3. Attempts at obtaining better diffracting crystals by Rrp44 engineering 
 
Since the diffraction of the Rrp44/Rrp41/Rrp45 sub-complex crystals was insufficient for 
structural analysis, different truncations of Rrp44 were attempted in an effort to obtain better 
diffracting crystals. 
 
2.3.1. Methods  
Target Identification 
Several truncations (Table 2-1) were identified by various methods.  The initial Rrp44ΔC (amino 
acids 1-270) had been identified by the EM reconstruction, and the remaining body region (270-
1001) was also attempted.  Additionally, a shorter truncation (1-242) was constructed based on 
the crystal structure of the C-terminal region of Rrp44 (12), and an even shorter version (17-242) 
removed the first several N-terminal amino acids that were predicted to be disordered using the 
PrDOS server (13) (Fig. 2-3A).  A region predicted to comprise the PIN domain (86-198) was 
also attempted, but proved to be insoluble and therefore it was omitted from further analysis.  
Limited proteolysis of the complex (Fig. 2-3B) or Rrp44ΔC (not shown) with trypsin, 
chymotrypsin, and elastase and subsequent mass spectrometry analysis determined that the first 
80 N-terminal amino acids were liable, as were amino acids 264-270 (Fig. 2-3B).  Therefore, 
three constructs based on the limited proteolysis results (50-263, 80-263, and 1-263) were made.  
Finally, a minimal N-terminal region of Rrp44 (17-242) was fused to a maltose binding protein 
(MBP) moiety in an attempt to improve crystal packing (construct MBP 17-242).   
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Table 2-1. Rrp44 truncations attempted for use in complex formation with Rrp41/45. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rrp44 Truncation 
(Residue #) 
Identity of Truncation Complex Formation 
With Rrp41/45 
1-270 (ΔC) N-terminal head extended into CSD1 Yes 
270-1001 C-terminal body No  
86-198 PIN Domain No (insoluble) 
50-263 Identified by limited proteolysis No 
80-263 Proteolyzed tail with smaller head No 
1-263 Full head and proteolyzed tail Yes 
1-242 Head without extension into CSD1 Yes 
17-242 Removes predicted unstructured region Yes 
MBP 17-242 MBP fusion with unstructured region removed No  
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Figure 2-3. Disordered prediction of Rrp44 and limited proteolysis of the 
Rrp41/45/Rrp44ΔC complex.  A) The amino acid sequence of Rrp44 was input to the PrDOS 
server (13) to determine possible disordered regions that could be removed to aid in 
crystallization.  Amino acids 1-17 at the extreme N-terminus as well a stretch between residues 
240 and 270 had a high probability of being disordered, and insight from this prediction was 
used to make the Rrp44 17-242 construct. B) Limited proteolysis time course of the 
Rrp41/Rrp45/Rrp44 1-270 complex using a molar ratio of 1:1000 of trypsin to complex.     
 
 
 
 
 
 
51 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
52 
 
Cloning, expression, purification, and complex formation analysis 
The truncations of Rrp44 (Table 2-1) were cloned into pLIC vectors and expressed in a manner 
similar to that of the Rrp44ΔC.  The maltose binding protein (MBP) chimera construct was made 
by cloning Rrp44 17-242 into a modified pMAL-c2 vector, which contained a rigid penta-alanine 
linker between the fusion site and the protein of interest (14).  The LB for the MBP-Rrp44 17-
242 was supplemented with 2 g glucose during expression.  Rrp44 plasmids were co-transformed 
with Rrp41/45 plasmid into BL21* cells, and selected for on plates containing kanamycin (or 
ampicillin for MBP Rrp44 17-242) and tetracycline.  Large scale expression and purification was 
completed using Ni-NTA chromatography, and was performed in a manner similar to that of 
Rrp44ΔC (Section 2.2.1), with the exception of MBP Rrp44 17-242.  Cell pellets of MBP Rrp44 
17-242 were resuspended in buffer containing 20 mM Tris pH 7.5, 150 mM NaCl, 5 mM 
betamercaptoethanol, 10% glycerol, and 1 mM PMSF.  The cell suspension was sonicated and 
the supernatant was bound to amylose resin, washed with 10 column volumes of buffer, and 
eluted with 10 mM maltose.  Single step protein purifications were then run through a MonoQ 
column and eluted with a gradient of NaCl to determine if they formed a stable complex with 
Rrp41/45.  
 
2.3.2. Results 
While all of the Rrp44 C-terminal truncations (amino acids 1-242 and 1-263) and the minimal N-
terminal truncation amino acids 17-242 were found to form stable complexes with Rrp41 and 
Rrp45, more extreme N-terminal truncations (aa 50-263, 80-263, and 270-1001) did not form 
stable complexes (see Fig. 2-4A for the 270-1001 result), suggesting that main source of 
 
53 
 
 
 
 
 
 
 
 
Figure 2-4. Association of truncated Rrp44 with Rrp41/45.  A) The C-terminal region of 
Rrp44 (amino acids 270-1001) was mixed with Rrp41/45 complex, and separated on a MonoQ 
column.  The chromatography resulted in two main peaks (not shown).  The first peak contained 
only Rrp44 270-1001, while the second peak contained only Rrp41/45. B) and C) Association of 
Rrp44 C-terminal truncations with Rrp41/45.  Complexes were purified by Ni-NTA, MonoQ, 
and gel filtration chromatography and analyzed on 10% polyacrylamide gels.  B) Rrp44 17-242 
+ Rrp41/45. C) Rrp44 1-242 + Rrp41/45. Rrp41 and Rrp44 1-242 run in overlapping positions.  
Abbreviations: M: molecular weight marker.  BL: protein sample before loading on the column. 
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association of Rrp44 with the exosome resided in the PIN domain of Rrp44, as was predicted 
from the EM reconstruction.  In addition, the MBP Rrp44 17-242 construct was found to 
dissociate from Rrp41 and Rrp45 during the initial amylose column purification; presumably this 
occurred because the MBP moiety was fused to the N-terminus of Rrp44 and thus sterically 
inhibited its interaction with Rrp41 and Rrp45.   
 
2.4. Crystallization screening of truncated Rrp44 complexes 
 
All of the Rrp44 truncations that successfully formed a complex with Rrp41 and Rrp45 (aa 1-
242, 1-263, and 17-242) were considered potential candidates for crystallization.  Large scale 
expression and multi-step purification (Ni-NTA, MonoQ, and size exclusion chromatography) 
was completed for these complexes (Fig. 2-4B-C for 1-242 and 17-242 complexes).  They were 
then concentrated to 10 – 20 mg/mL and nano-crystal screening using sitting drop trays and 
volumes of ~0.1-0.3 µL using the Phoenix Crystallization Robot at the Weill Center for 
Molecular and Cell Biology.  However, no obvious crystal hits were obtained from screening.   
Although MBP Rrp44 17-242 did not form a complex with Rrp41/45, it still served as a 
potential crystallization target because the structure of the N-terminal PIN domain of Rrp44 was 
unknown at that time.  MBP Rrp44 17-242 was further purified on a MonoQ column (Fig. 2-5A), 
which removed excess MBP that inevitably results during over-expression.  The protein was 
concentrated for crystallization screening in buffer containing 20 mM Tris pH 8.0, 150 mM 
NaCl, 3 mM MnCl2, and 1 mM DTT.  Initial screening at protein concentrations of ~10 mg/mL 
produced only clear drops, most likely because the MBP tag is a solubility enhancer and thus 
prevents the protein from precipitating out of solution.  The remainder of the protein stock was 
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therefore further concentrated to 28 mg/mL and tested for crystallization using nano scale sitting 
drop trays.  After incubation of approximately 1 month, crystals appeared in a precipitation 
condition containing 0.2 M NaCl, 0.1 M HEPES pH 7.5, and 10% v/v 2-propanol (Fig. 2-5B).  
The entirety of these crystals were washed and run on SDS-PAGE, and appeared to contain the 
protein of interest (Fig. 2-5C).  However, crystals were not readily reproducible using large scale 
crystallization optimization with different batches of protein, even at higher protein 
concentrations up to 46 mg/mL.  It is possible that crystallization was simply not reproducible 
when scaling up to large scale screens.  Another possibility is that differences in purity between 
the two protein batches caused crystallization problems.  It is also possible that free MBP 
impurities resulted in prior crystallization, and subsequent batches were purified to a greater 
degree to remove free MBP. 
2.5. Hetero-assembly of Rrp44 from different organisms with yeast Rrp41/Rrp45  
 
In a combined effort to search for new crystallization targets of the Rrp44/Rrp41/Rrp45 complex 
as well as to probe the evolutionary conservation of interaction of Rrp44 with Rrp41 and Rrp45, 
purification of Rrp44 proteins from organisms other than S. cerevisiae were attempted and tested 
for their ability to form a complex with yeast Rrp41/45.  The organisms that served as a source 
of Rrp44 proteins were Schizosacchromyces pombe and Homo sapiens, and regions homologous 
to the crystallized fragment of yeast Rrp44 (aa 1-270) were determined by sequence alignment 
(Fig. 2-6).  At the time of this research, human Rrp44 (hDis3) had been shown to complement 
yeast cells depleted of Rrp44 (15), but it had not yet been demonstrated that it bound to the 
human exosome core. 
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Figure 2-5. Purification and Crystallization of MBP Rrp44 17-242.  A) MonoQ purification.  
Pure MBP Rrp44 17-242 was contained in a late eluting peak, while free MBP bound less readily 
to the column and eluted earlier.  B) Crystals produced in 0.2 M NaCl, 0.1 M HEPES pH 7.5, 
and 10% v/v 2-propanol at protein concentration of 28 mg/mL.  C) Washing the crystals and 
running them on a gel produced a band indicative of the molecular weight of the fusion protein.  
M is the molecular weight marker, SN is the supernatant produced after centrifuging crystals, 
W1 and W2 are washes 1 and 2, and Xtal is the crystal.   
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2.5.1. Methods 
 
Cloning 
Human Rrp44 amino acids 1-215 was PCR amplified from cDNA from both cardiomyocytes and 
MCF-7 cells (kindly provided by the Kraus lab) using primers with a 5’ end BamHI site and 3’ 
end XhoI site.  While initial amplification attempts using a standard PCR program were 
unsuccessful, a touchdown PCR program (16) was used to successfully amplify the region.  The  
PCR product was digested with XhoI and BamHI and ligated into a vector containing an  
N-terminal hexahistidine SUMO fusion and kanamycin selective marker (pSUMO, kindly 
provided by the lab of Holger Sondermann).  Ligated products were transformed into DH5α cells 
and grown on kanamycin selective plates.  Single colonies were picked and mini-preped to 
isolate plasmids, and plasmids were confirmed to contain the insert of interest by DNA 
sequencing.   
Interestingly, sequencing revealed cell specific isoforms of human Rrp44.  Plasmids 
constructed using PCR products from reactions containing cDNA from cardiomyocytes as a 
template contained the full length N-terminal region of human Rrp44 (also known as hDis3, and 
listed in pubmed as isoform a), while those that used MCF-7 cDNA as a template contained a 
shorter N-terminal region (Fig. 2-7A) that also had about 20 different amino acids (listed in 
pubmed as isoform b), which appears to result from alternative splicing, and has no relation to 
the other “canonical” human isoforms (hDis3L1 or hDis3L2).  This region is well conserved in 
higher eukaryotes (Fig. 2-7B), but its function is unknown.  Notably, in isoform b there is a 
deletion for a residue involved in endonuclease activity in yeast Rrp44 (D91 using yeast 
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numbering).  Plasmids encoding the full length human Rrp44 and the N-terminal truncation 
amino acids 215-end were also constructed in a similar fashion.  Plasmids were transformed into 
BL21* cells for use in protein purification.  S. pombe Rrp44 amino acids 1-235 was PCR 
amplified from genomic DNA (kindly provided by the laboratory of Jeff Pleiss), using primers 
containing a 5’ end BamHI site and 3’ end XhoI site.  A bridging PCR method with overlapping 
primers was used to remove introgenic regions from the PCR product, and touchdown PCR was 
successfully used to amplify the protein coding region.  S. pombe Rrp44 1-235 was ligated into 
the pSUMO vector and confirmed by sequencing in a manner similar as that described for human 
Rrp44, before being transformed into BL21* cells in preparation for protein expression. 
Protein Expression and Purification 
Expression and purification steps were similar for all proteins.  Cultures were grown in 3 L of 
LB media at 37 °C until reaching OD600 of 1.7, at which time they were induced with 1 mM 
IPTG overnight at 18 °C.  Proteins were purified by Ni-NTA chromatography using procedures 
similar to those mentioned earlier.  While purifications of S. pombe Rrp44 amino acids 1-235 
and human Rrp44 1-215 isoform a were successful, isoform b appeared to express poorly, and 
human Rrp44 full length and C-terminal truncation both appeared to be proteolyzed into several 
bands during purification; therefore, these proteins were omitted from further analysis.  The 
SUMO fusion tag was cleaved by overnight incubation with yeast Sm3t SUMO protease at 4° C.  
During cleavage, proteins were dialyzed into buffer containing 20 mM Tris pH 8.0, 50 mM 
NaCl, 5 mM betamercaptoethanol, and 10% glycerol in order to lower the salt concentration and 
to remove imidazole.  Imidazole free proteins were then run through a second nickel column to 
remove the hexahistidine SUMO tag, loaded onto a heparin column, and eluted with a gradient 
of NaCl.  Purified proteins were analyzed by SDS-PAGE (Fig. 2-8) and concentrated. 
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Figure 2-6. Sequence alignment of the N-terminal region of Rrp44 from various 
eukaryotes.  Sequences from several common organisms were aligned using the ClustalW 
server (17).  The border of the N-terminal region (amino acid 242 in S. cerevisiae) is boxed in 
red. 
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Figure 2-7. Sequence conservation between two isoforms of human Rrp44 (hDis3).  A) 
Alignment of hRrp44 isoforms.  B) Alignment of Rrp44 in higher eukaryotes.  The boxed region 
is well conserved in higher eukaryotes, but differs between the two human isoforms.  Alignments 
were performed with ClustalW (17). 
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Complex Formation Studies 
Proteins were used in complex formation assays with Rrp41/45.  Human Rrp44 1-215 or S. 
pombe Rrp44 1-235 were separately mixed in a 1.5:1 molar ratio with S. cerevisiae Rrp41/45 and 
incubated for 30 minutes on ice.  The mixtures were then loaded onto a Superdex S200 size 
exclusion column and run in buffer containing 20 mM Tris pH 8.0, 150 mM NaCl, and 1 mM 
DTT at a flow rate of 0.25 ml/min.  Peak fractions were analyzed by SDS-PAGE.  Human Rrp44 
1-215, S. pombe Rrp44 1-235, and Rrp41/45 were also run alone using the same column for  
comparison, and chromatographs (not shown) for runs of the single proteins were used as elution 
volume references. 
2.5.2. Results 
Chromatographs of both assays consisted of two prominent peaks (Fig. 2-9).  In both cases, the 
first peak ran in a position coincident with that of Rrp41/45 alone (not shown) and subsequent 
SDS-PAGE analysis indicated that the peak contained only Rrp41/45, while the second peak 
eluted at a volume representative of the Rrp44 protein and contained either only human Rrp44 1-
215 or S. pombe Rrp44 1-235 (Fig. 2-9A-B).  These results indicate that the association of Rrp44 
with the exosome core is different enough to the extent that heterogeneous assembly failed.  A 
recent report indicates that hDis3 can bind to the human exosome but the association is very salt 
sensitive (stable at only 75-100 mM of NaCl) (4), so it is possible that the salt concentration used 
in this study (150 mM NaCl) was too high.  However, this seems unlikely, given that yeast 
Rrp44 does not dissociate from the yeast exosome at NaCl concentrations of 500 mM.  It is more 
likely that the human exosome associates with Rrp44 in a manner different than the yeast 
exosome.  While human Rrp44 (hDis3) can complement Rrp44 yeast depleted cells (15), it is 
possible that this does not require binding of Rrp44 to the exosome.  The human exosome could  
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Figure 2-8. SDS-PAGE analysis of S. pombe Rrp44 Truncations.  Gels represent protein 
purity after two step purification (Ni-NTA and heparin).  A) S. pombe amino acids 1-235. B) 
Human isoform a amino acids 1-215  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
65 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
66 
 
 
 
 
 
 
Figure 2-9. Rrp44 complex formation assayed by size exclusion chromatography. Rrp44 
proteins were mixed in a 1.5:1 molar ratio with Rrp41/45 and run through a Superdex S200 size 
exclusion column.  A) Human Rrp44 1-215 + Rrp41/45.  B) S. pombe Rrp44 1-235 + Rrp41/45.  
In both cases, two peaks appeared in the chromatography.  The first peak was centered at an 
elution volume of about 14 mL, and contained only Rrp41/45 as analyzed by SDS-PAGE.  The 
second peak was centered around and elution volume of about 16 mL, the same elution volume 
for the Rrp44 proteins alone (not shown) and contained only the Rrp44 protein on SDS-PAGE. 
C) Size exclusion chromatography analysis of the S. cerevisiae Rrp44 1-270 + Rrp41/45 
complex for means of comparison.  In this chromatograph, the first peak contains the ternary 
complex, while the small second peak contains excess Rrp44. 
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also require a larger region of Rrp44 to bind to in order to form a stable association with the 
exosome core than just the N-terminal region of Rrp44, or make contacts with different exosome 
core subunits.  Therefore, a continuation along this line of inquiry was planned to clone out 
Rrp41 and Rrp45 from human and S. pombe, purify them, and to test assembly of the organism 
specific ternary complexes with Rrp44 for use in crystallization screening. 
 
2.6. Ideas on a complex containing the full length Rrp44 and Rrp41/45 
 
While work on cloning of the human and S. pombe Rrp41 and Rrp45 commenced, an attempt to 
form the S. cerevisiae ternary complex using the full length Rrp44 was planned.  Initially, the 
minimal ternary complex containing only the N-terminal region of Rrp44 was rigorously pursued 
because Rrp44 was predicted from the EM reconstruction results to contain a flexible linker 
joining the N and C terminal regions (6), which could make crystallization of the full length 
Rrp44 difficult.  On the other hand, since structural studies of the minimal ternary complex of the 
N-terminal region of Rrp44 bound to subunits Rrp41 and Rrp45 at best only produced poorly 
diffracting crystals (Section 2.2), it was envisioned that using a complex containing the full 
length version of Rrp44 bound to Rrp41/45 could provide more regions of protein contact, which 
could improve crystal packing and ultimately provide better diffracting crystals.  Work was 
begun on purifying the yeast full length Rrp44 + Rrp41/45 ternary complex; however, before 
crystallization screening of the complex was completed, another group solved a similar structure 
and published their report (18).  Unfortunately, this report rendered crystallization of both MBP 
Rrp44 17-242 and the Rrp44ΔC/Rrp41/Rrp45 ternary complex superfluous.  Since cloning of 
human and S. pombe Rrp41 and Rrp45 subunits had not yet begun, it was abandoned.  
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2.7. Relation of the published ternary structure to our efforts 
 
Since the Rrp44/Rrp41/Rrp45 ternary complex structure has been published by the Conti group 
(18), it will only be covered briefly and with an emphasis on its relation to prior work completed 
by the Ke group.  Overall, experiments conducted by the Conti group concerning the association 
of Rrp44 with the exosome core agreed well with our results.  Similar to our results, they found a 
stable association of Rrp44 with the exosome subunits Rrp41 and Rrp45, and they reported that 
deleting the PIN domain of Rrp44 resulted in a loss of association with the exosome core (18). 
For crystallographic studies, the Conti group used the S. cerevisiae Rrp44 truncation amino acids 
25-1001, which was reportedly determined using limited proteolysis of the Rrp44 PIN domain, 
which was used within the physiological C-terminal region of the protein, and crystallized in 
complex with full length versions of S. cerevisiae Rrp41 and Rrp45 (18) .   
The PIN domain of Rrp44 serves as the main site of interaction with the exosome core.  PIN 
domain residues 37-71 interact with Rrp41 residues N-terminal residues (Fig. 2-10A), and the 
interaction is held together by the formation of salt bridges of residues Glu10, Arg18, and Glu21 
of Rrp41 to residues Arg133, Asp44, and Arg42 of Rrp44, respectively (18).  Although our 
results agree with those of the Conti group that N-terminus of Rrp44 was necessary and 
sufficient for association with the Rrp41/45 sub-complex, the crystal structure of the ternary 
complex revealed that the C-terminal region of Rrp44 was found to bind to regions on both 
Rrp41 and Rrp45 as well.  The CSD2 domain of Rrp44 was found to interact with Rrp45 via 
electrostatic interactions between charged residues.  The RNB domain of Rrp44 binds to two 
surfaces of the Rrp41/45 dimer; in particular, it interacts with the C-terminal tail of Rrp45  
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Figure 2-10.  Crystal structure of the Rrp44/41/45 ternary complex and docking of the 
structure into the yeast exosome EM reconstruction. A) Crystal structure of the Rrp44 25-
1001/Rrp41/Rrp45 structure (pdb 2wp8).  Rrp41 and Rrp45 are in solid colors, while Rrp44 is 
color coded by domain.  Regions of interaction between Rrp44 and Rrp41 and Rrp45 occur 
mainly between loops and are indicated by circles.  This figure was created in PYMOL (19).  B)  
The crystal structures of the human exosome (1) (pdb 2nn6), after omitting subunits Rrp41, 
Rrp45, and Csl4, and the S. cerevisiae Rrp41/Rrp45/Rrp44 25-1001 ternary complex (18) (pdb 
2wp8) were docked into the EM reconstruction of the yeast exosome (6) using the program 
UCSF Chimera (20).  Rrp44 is in solid red-orange, while Rrp41 and Rrp45 are colored following 
the same color scheme as Fig. A.  On the left, the ternary complex structure was docked in its 
entirety.  On the right, the N and C-terminal regions of Rrp44 were separated before docking. 
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(residues 293-303) by means of hydrophobic and polar contacts (18).   We initially identified 
several stable ternary complexes of Rrp44 to Rrp41 and Rrp45, and our studies produced an N-
terminal truncation of Rrp44 (Δ17) that was very similar to that used by the Conti group (Δ25).  
We were also correct that the N-terminal PIN domain region of Rrp44 was necessary and 
sufficient for attachment to the exosome; however, C-terminal regions of interaction within 
Rrp44 were more difficult to predict.  Ultimately, these C-terminal interactions may have 
provided more crystal contacts, which could have aided in producing better diffracting crystals 
and a high resolution structure. 
Another reason why crystallization could have been impeded was the manner in which 
the ternary complex was assembled.  In the study published by the Conti group (18), the complex 
was assembled by mixing Rrp44 with the Rrp41/45 complex, further purifying it, and pooling 
fractions containing the complex for crystallization.  The initial manner in which we purified the 
Rrp44 1-270/Rrp41/45 complex followed similar methods, and crystallized readily.  However, in 
order to reduce the amount of labor for further studies, purification of subsequent complexes was 
completed using co-expression instead of mixing, but none of these complexes crystallized.  
Therefore, it is possible that co-expression of the ternary complex resulted in poorly assembled 
or sub-stoichiometric complexes, which impeded crystallization.  During co-expression, it was 
noticed that the Rrp41/45 complex always had a much higher level of expression than that of the 
Rrp44 protein, and excess Rrp41/45 was always collected during second step MonoQ 
purification.  We noticed a similar situation occurred when purifying recombinant exosomes 
using a co-expression technique (see Chapter 3).  Exosomes expressed in this manner also had an 
over-abundance of Rrp41/45 before MonoQ separation, and were poorly assembled when viewed 
under EM (21, 22).  Therefore, it is possible that the Rrp44/Rrp41/Rrp45 ternary complexes 
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purified using co-expression could have been improperly assembled as well. 
 
2.8. Relevance of the ternary complex structure in the context of the intact exosome 
 
While the Rrp44/Rrp41/Rrp45 ternary complex provides insight into how Rrp44 associates with 
two subunits of the exosome core, it is important to know whether this structure is relevant 
within the physiological context of the complete exosome core.  In order to gain insight into how 
Rrp44 associates with the whole exosome, the crystal structure of the Rrp44/Rrp41/Rrp45 
ternary complex along with the structure of the human exosome core (after deleting subunits 
Rrp41, Rrp45, and Csl4) was docked into the EM reconstruction of the Rrp44 bound yeast 
exosome (6).  As shown in Fig. 2-10B, and as reported previously (6) the human exosome core 
docks into the yeast exosome EM reconstruction quite well, despite the fact that it is from a 
different organism.  The N-terminal PIN region of Rrp44 partially docks into the EM 
reconstruction, while the C-terminal body region of Rrp44 docks rather poorly into the density 
from the EM reconstruction (Fig. 2-10, left).  A much better docking result can be obtained when 
separating the N and C-terminal regions of Rrp44 and docking them separately (Fig. 2-10, right).   
The EM reconstruction of the Rrp44 exosome suggested that the PIN domain of Rrp44 is 
separated from the C-terminal region by about 20 Å, while the crystal structure of the ternary 
complex suggests a much closer proximity.  Therefore, it is possible that the conformation of the 
PIN domain seen in the crystal structure is the result of a crystal packing artifact and may not 
accurately reflect how Rrp44 associates with the core exosome.  Further crystallographic studies 
of a complete Rrp44 bound exosome would resolve the disparities between the present crystal 
structures and EM reconstruction. 
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The published structure of the Rrp44/Rrp45/Rrp41 ternary complex also raised questions about 
how RNA interacts with Rrp44 when this subunit is bound to the exosome.  A prior structure of a 
truncated Rrp44 without the PIN domain solved in complex with single stranded, polyadenine 
RNA (12) suggested that the RNA made most of its contacts in the RNB domain of Rrp44.  In 
the RNA bound structure of Rrp44ΔPIN, amino acids 696-719 fold into a short beta sheet and 
loop that is involved in RNA binding (Fig. 2-11, left) (12).  However, in the Rrp44/Rrp41/Rrp45 
structure, this same region is blocked by a conformation change in Rrp44, in which residues 696-
719 fold into a short helix (Fig. 2-11, right), and it was suggested that this inhibited 
conformation could be stabilized upon Rrp44 binding to the exosome since residue R303 from 
Rrp45 could electrostatically repel residue K702 from Rrp44 which is involved in RNA binding 
(18).  Biochemical results also suggest that a single stranded RNA of 31-33 nucleotides is 
channeled through the exosome core and then degraded by Rrp44 (18)  (discussed in greater 
detail in Chapter 3), in a manner reminiscent of the archaeal exosome, and suggest that the 
previous reported RNA access pathway may thus be irrelevant for activity when Rrp44 is bound 
to the yeast exosome.  However, such as recruitment pathway could be relevant for Rrp44 like 
enzymes in humans, such as Dis3L2, which lacks a PIN domain and presumably does not bind to 
the exosome.  The RNA access route depicted in the Rrp44ΔPIN structure could also be relevant 
for a “direct access pathway” of RNA degradation by the exosome, which was initially proposed 
based on structural comparison of Rrp44 with the homologous bacterial enzyme RNase II (23, 
24).  This direct access pathway will be studied in greater biochemical detail through the use of 
biochemical assays in the next chapter.     
 
2.9.  The RNA binding channel is blocked in the Rrp44ΔPIN structure as well. 
The assumption that the exosome regulated Rrp44 by stabilizing an inhibited  
75 
 
 
 
 
Figure 2-11.  Comparison of the active sites of the Rrp44/Rrp41/Rrp45 structure with that 
of the Rrp44ΔPIN RNA bound structure.  In the Rrp44ΔPIN RNA bound structure (left), 
amino acids 696-719 form a short beta sheet and loop involved in RNA binding in the active site.  
In the Rrp44/Rrp41/Rrp45 structure (right), the active site is blocked by a conformational change 
that causes this region to fold into a short alpha helix and loop.  Figure illustrated with PYMOL 
software (19).  
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conformation that blocks its active site upon binding, as suggested by the Conti group (18), is an 
interesting yet untested hypothesis.  Since the Rrp44 region 696-719 occluded the RNA access 
route deep within the Rrp44 active site channel (18), it would be difficult to determine how RNA 
would be degraded at all when Rrp44 assumed such a conformation.  Since no apo structure of 
Rrp44ΔPIN had been solved, it is possible that the “open state” of the active site channel of 
Rrp44 was caused by binding to RNA.  Moreover, little evidence was present to suggest that the 
inhibited conformation of Rrp44 could be stabilized by Rrp45, since the conformation of this 
protein could change upon RNA binding as well.  In order to clear up this discrepancy, we set 
about to solve the structure of the Rrp44ΔPIN apo structure.     
 
2.9.1. Methods 
Cloning, expression, and protein purification 
N-terminal hexahistidine tagged Rrp44 242-1001 exonuclease mutant (D551N) was amplified 
from a plasmid containing this mutation, restricted with NcoI and XhoI enzymes, and ligated into 
a pET19b vector.  The protein was expressed and purified by Ni-NTA chromatography using 
methods similar to those described previously for other Rrp44 proteins, and underwent a final 
MonoQ purification step.  Protein was then dialyzed overnight into 10 mM Tris pH 8.0, 150 mM 
NaCl, 1 mM DTT, and 2.5 mM MgCl2.  Protein was concentrated to 30.4 mg/mL, snap frozen, 
and stored at -80 °C until use. 
Crystallization 
Protein at a concentration of 15.2 mg/mL was crystallized using hanging drop wells over a 
reservoir of 50 mM MES pH 6.0, 150 mM NaCl, 1 mM DTT, 2.5 mM MgCl2, and 12% PEG 
400.  Crystals appeared as thin plates (Fig. 2-12A). 
77 
 
Data Collection and Structure Determination 
Protein crystal diffraction data was collected at CHESS beamline A1.  Phase information was 
obtained by the molecular replacement using the Rrp44ΔPIN RNA bound structure (pdb 2vnu) 
(12) as a model.  The model was fit into the electron density using coot (25), and underwent rigid 
body refinement in CNS (26), followed by further refinement in REFMAC (27) from the CCP4 
software suite (28).  Crystallization statistics are found in Table 2-2. 
 
2.9.2. Results 
 
In the structure of Rrp44ΔPIN apo, four molecules (A, B, C, and D) were found in the 
asymmetric unit (Fig. 2-12B), and aligned with a root mean squared deviation of 0.65 – 0.69 Å 
(Fig. 2-12C).  Although the structure of the Rrp44ΔPIN apo was of a lower resolution (3.2 Å) 
than the RNA bound form (2.3 Å), an overall similar domain organization could be determined 
(Fig. 2-12D) and agreed well with that of both the RNA bound form (pdb 2vnu) as well as the 
Rrp44/41/45 structure (pdb 2wp8). 
   Three (molecules A, B, and D) out of four molecules contained continuous electron 
density around the active site channel (amino acids 696-719), while poorer density was present 
for this region in molecule C (Fig. 2-14A-B).  This region folds into a short alpha helix and loop 
that encompasses the RNA binding region of the active site, and assumes a conformation almost 
identical to that found in the structure of the Rrp44/Rrp41/Rrp45 ternary complex (Fig. 2-14 C).  
Therefore, it appears that the active site is inhibited in the apo form of Rrp44, and that binding to 
RNA causes a conformational change that allows for RNA entry and subsequent degradation.  
Further studies will need to be conducted to determine whether a conformational change occurs  
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Table 2-2.  Crystallography Statistics of Rrp44ΔPIN Apo 
Parameter  Rrp44ΔPIN Apo  
Beamline  MacCHESS A1  
Space group  P64  
Unit cell parameters (Å)  a = b = 145.50, c=309.97 
Wavelength (Å)  0.9770 
Resolution range (Å)  50 – 3.2  (3.26  3.20 )  
Measured reflections  174736  
Rwork (%)  26.02  
Rfree    (%)  30.02  
Unique reflections  55433  
Redundancy  3.2 (2.0)  
Completeness  90.6 (80.7)  
Average I/σ(I)  9.08 (1.58)  
Rmerge (%)  11.8 (30.5)  
Molecules per Asymetric 
unit  
4  
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in the exosome subunits upon RNA binding as well.   
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Figure 12-12.  Crystallization and structure of Rrp44ΔPIN apo.  A) Plate crystals of the 
proteins.  B) Asymmetric unit of Rrp44ΔPIN apo containing four molecules.  C) Alignment of 
the four molecules found within the asymmetric unit.  D) Domain organization of one monomer 
(molecule A) agrees well with other published Rrp44 structures.  The color scheme of the 
domains is the same as that in figure 1-3.  Figures B and C are courtesy of Ki Hyun Nam. 
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Figure 12-13.  The active site of Rrp44 apo.  A) Electron density for molecule B indicating 
good density for the region of residues 696-719 and B) poorer density for this region found in 
molecule C.  C) The active site of Rrp44ΔPIN apo assumes the same conformation as that of the 
ternary complex between Rrp44/Rrp41/Rrp45 (pdb 2wp8).  This figure was created with 
PYMOL (19).  Figures A and B are courtesy of Ki Hyun Nam. 
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Chapter 3: Biochemical studies of Rrp44 and the Rrp44 bound exosome 
 
Abstract 
This chapter entails the use of yeast exosomes for activity assays with structured RNA substrates 
containing with various 3’ end tail lengths.  We first detail the purification of wild type yeast 
exosomes using the TAP method and the reconstitution of core exosomes with mutated Rrp44.  
Rrp44 and Rrp44 containing exosomes were then used in both exo- and endo- nuclease assays 
with both 3’ end extended forms of both the Hepatitis Delta Virus Ribozyme as well as yeast 
initiator methionine tRNA.  We find that a 3’ end tail length of ~8-9 nucleotides is necessary for 
exonuclease degradation by Rrp44, while degradation by the exosome is down-regulated and 
only occurs with a tail length of about 20 nucleotides.  This tail length is ~10-13 nucleotides 
shorter than the nucleotide length required to span from the entrance of the exosome channel to 
the active site of Rrp44, indicating a direct access pathway to Rrp44 for degradation.  
Furthermore, we show that while the N-terminal endonuclease PIN domain of Rrp44 can degrade 
single stranded regions of structured RNA promiscuously, association with the exosome results 
in the restriction of degradation to the 3’ end tail of the RNA.  The PIN domain was also shown 
to contribute to RNA binding to structured substrates.  The fact that the 3’ end tail of the RNA 
can be degraded by both exo and endonuclease activities place the RNA in a position to interact 
with both the N- and C-terminal regions of Rrp44.  When taken together with the length 
requirement of RNA degraded and collaborative EM reconstruction and single molecule studies, 
we propose that RNA can access Rrp44 when bound to the exosome by using an RNA entrance 
pathway reminiscent of RNase II.    
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3.1. Introduction 
 
The EM model of the yeast exosome (1) suggested two possible routes of  RNA recruitment to 
the exosome: 1) the through exosome route, in which RNA passes through the core exosome 
channel and is then feed into Rrp44 for degradation, and 2) the direct access route in which RNA 
is directly recruited to Rrp44 while avoiding the exosome channel.  At this time, evidence from 
the Conti group indicates that single stranded RNA is degraded via the through exosome route 
(2).  The research group made mutations in the entry and exit sites to the RNA channel in the 
exosome core and showed that degradation of single stranded RNA was inhibited (2).  However, 
the experiment was somewhat biased since it was conducted by pre-binding substrates with 
purified recombinant core exosomes, thus favoring exosome channeling, before adding Rrp44 
for degradation assays.  The report indicated that a length of 31-33 nucleotides was required to 
reach from the entrance of the exosome to the active site of Rrp44 for degradation (Fig. 3-1A, 
left) (2).  While this model explains a probable route for single stranded RNA degradation, it 
does not explain how more structured substrates can be degraded by the exosome. 
Although the through exosome route appears to be the favored pathway for degradation 
of single stranded RNA, little work has been conducted to test the direct access route.  In 
particular, the direct access route is an intriguing pathway for structured RNA substrates.  
Evidence to support the existence of this route includes the fact that in the co-crystal structure of 
Rrp44ΔPIN bound to RNA, the 5’ end of the RNA is pointed towards solvent (Fig. 3-1A, left), 
indicating that this pathway is not continuous with the exosome core (3).  Furthermore, a second 
pathway into the active site of Rrp44 could occur which is more reminiscent of the E. coli 
enzyme RNase II (4) (Fig. 3-1A, left).  Also, the PIN domain  
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Figure 3-1. Mechanisms of RNA processing and unwinding by Rrp44. A) Reported pathway 
of Rrp44 mediated degradation by the exosome, shown as a dashed line.  A length of 31-33 
nucleotides is reported to reach from the entry site of the exosome core to the active site of 
Rrp44 (2).  Depicted is the docking of the crystal structures of the Rrp44/Rrp41/Rrp45 complex 
(pdb 2wp8) and the human exosome, with Rrp41, Rrp45, and Csl4 subunits removed, (pdb 2nn6) 
into the EM reconstruction of the Rrp44 bound exosome (gray envelope, EM Databank ID 
1438).  Docking was performed with UCSF Chimera (5).  B) Crystal structure of Rrp44ΔPIN 
(light shades, pdb 2vnu) aligned with RNase II (dark shades, pdb 2ixi) with domains color coded 
and RNA access routes depicted.  C) Proposed mechanism of unwinding of duplex RNA by 
Rrp44.  Circles represent domains of Rrp44, and are colored according to the scheme in B.  
Depicted above the CSD2 and S1 domains is a cartoon spring to represent how these domains 
compress and release during RNA degradation.  This figure is based on data from a single 
molecule FRET study (6).  
89 
 
 
90 
 
of Rrp44 contains endonuclease activity (7-9).  The active site of the PIN domain of Rrp44 is 
also solvent exposed (Fig. 3-1A, left), so it does not appear to be in a position to interact with 
RNA emerging from the exosome core (2).  Recent preliminary negative stain EM reconstruction 
efforts conducted in collaboration between the Ke and Wang groups indicate that the C-terminal 
region of Rrp44 undergoes a ~90° conformational change upon structured RNA binding, 
bringing it closer to the PIN domain (10) (Fig. 3-1A, right).  Since the conformational change 
occurs only in Rrp44 and not any subunits of the exosome core subunits, it suggests that RNA is 
directly binding to Rrp44 in a direct access manner, and RNA binding would likely open up the 
active site of Rrp44 which was blocked in the Rrp44ΔPIN apo, and Rrp44/Rrp41/Rrp45 (2) 
structures.  Moreover, since the conformational change occurs within a region in close proximity 
of the RNase II like direct access degradation, this route is favored over the solvent exposed 
pathway into the active site of Rrp44.  Further cryo-EM studies will need to be conducted to 
visualize the position of the RNA and to confirm the veracity of this hypothesis. 
The ability of the exosome to degrade structured RNAs that are too large to pass through 
the core channel is reconciled by evidence that these substrates can be unwound by helicase 
containing complexes such as the nuclear TRAMP complex (11-13).  Numerous studies have 
been conducted to show that the nuclear exosome can be activated by the TRAMP complex to 
degrade RNA (11-13), which has also be reported to ―activate‖ the exosome.  The majority of 
studies conducted with the TRAMP complex, however, do not differentiate between the 
degradation activity of Rrp6 and Rrp44 in exosome preparations.  Furthermore, more recent 
reports indicate that the activity of Rrp6 is most likely activated by TRAMP, but the activity of 
Rrp44 is not (14, 15).  Few degradation studies have been conducted using the Rrp44 bound 
exosome in the absence of other helicase factors such as the TRAMP complex.  However, one 
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study did indicate that Rrp44 could partially, yet selectively, degrade an initiator methionine 
tRNA that was hypomethylated on nucleotide A58, out of a pool of RNA (13).  Although it is 
possible that the tRNA was partially unfolded due to the missing methylation site, it is unlikely 
that it would have had an exposed 3’ end of 31-33 nucleotides that could have been fed into the 
exosome channel.  This suggests that partially folded tRNA may be able to access the Rrp44 
bound exosome via the direct access pathway. 
Although the nuclear TRAMP complex and cytoplasmic SKI complex both contain 
helicase activities which could activate substrates for exosome mediated degradation, evidence 
indicates that the Rrp44 bound exosome contains an intrinsic helicase activity itself (3).  The 
Conti group previously showed that duplex substrates with a 3’ end of at least 7 nucleotides 
could be unwound and degraded by the Rrp44 alone (3), while duplexes with a 3’ end of 35 
nucleotides could be unwound and degraded by the Rrp44 containing exosome (2).  Furthermore, 
a study conducted by the Ha lab (University of Illinois—Urbana Champagin) in collaboration 
with the Ke group indicted that Rrp44 first degrades a short single stranded overhang and then 
unwinds the duplex in discrete step sizes of 4-5 bp/step (6).  It was proposed that about seven 
nucleotides of the 3’ overhang of the substrate are bound in the active site of Rrp44 during 
degradation, leaving the single/double stranded RNA junction in proximity to CSD1 and CSD2.  
The CSD domains abut this junction and are positioned to act as ―wedges‖ while the RNB 
domain degrades 4-5 additional nucleotides.  This causes tension in the 3’ single stranded tail 
and accumulates elastic energy that is utilized to unwind several base pairs of duplex RNA in a 
burst fashion, resulting in the movement of the CSD wedges (Fig. 3-1C).  This cycle is continued 
until the double stranded RNA region is transversed.  Thus, the data show that Rrp44 acts as an 
―elastic helicase‖ to unwind RNA using the hydrolysis of the single stranded overhang to drive 
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the reaction (6).  If a similar mechanism exists while Rrp44 is bound to the exosome core, this 
helicase ability may be relevant to degrade structured substrates by the direct access pathway 
without the use of either the TRAMP or SKI complexes. 
In order to more thoroughly determine whether a direct access pathway of degradation to 
the exosome occurs, we tested a number of structured substrates with Rrp44 and Rrp44-bound 
exosomes in degradation assays.  The main substrates tested were the Hepatitis Delta Virus 
ribozyme and hypo-modified initiator methionine tRNA.  Substrates used had a structured core 
followed by a 3’ end overhang extension of various lengths.  The 3’ end tail was added to serve 
as a ―molecular ruler‖ to determine the length of single stranded RNA that was required to be 
actively degraded by either Rrp44 or the exosome, to demonstrate whether a direct access route 
to Rrp44 occurred, which would be indicated by degradation of a 3’ end region that spanned a 
distance of less than 31-33 nucleotides—the reported length from the exosome ring to the active 
site of Rrp44 (2).  Identification of such as pathway will more holistically characterize the 
catalytic mechanism of the eukaryotic exosome. 
 
3.2. Purification of recombinant Rrp44 bound exosomes via cotransformation 
 
In order to study the activity of the exosome, it is essential to purify stable Rrp44 bound 
exosomes for biochemical assays.  The eukaryotic exosome is composed of three heterodimers 
(Rrp41/Rrp45, Rrp43/Rrp46, and Rrp42/Mtr3) and three RNA binding ―capping‖ proteins (Rrp4, 
Csl4, and Rrp40), which bind at an interface created between adjacent heteordimers (16).  Our 
results, as well as those from others (17, 18) indicate that while the heterodimers purify well 
when expressed with their respective binding partner, they express poorly alone.  It has been 
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suggested that co-expression of proteins with their binding partner buries hydrophobic residues 
that cause the proteins to be insoluble when expressed alone (17).  In order to avoid insolubility 
issues during purification, we initially attempted a co-expression procedure.  Previous published 
methods detailed the assembly of exosomes by mixing the three individually purified 
heterodimers with the three capping proteins and then purifying the complex (17).  The goal of 
our procedure, however, is to co-express the exosome in as few steps as possible, and is 
described below.   
 
3.2.1 Methods 
 
Cloning 
Three polycistronic vectors containing the majority of the exosome genes were used for the 
purpose of co-expression, and were constructed by Ben Clarke, a former rotation student in the 
lab, and Fran Ding.  Polycistronic insert regions of exosome genes Rrp42-Mtr3-Rrp43; Rrp45-
Rrp41-Rrp46; and Rrp4-Rrp40 were amplified from genomic DNA, and cistrons were created 
using overlap extension PCR (18), and inserted into vectors containing N-terminal hexahisidine 
tags for purification as summarized in Fig. 3-2.  The Rrp42-Mtr3-Rrp43 insert was ligated into a 
pET23a vector containing ampicillin resistance using 5’ KpnI and 3’ BamHI restriction sites.  
The Rrp45-Rrp41-Rrp46 pACYC184 vector was prepared as discussed previously (Chapter 
2.2.1).   The Rrp4-Rrp40 insert was cloned into a pLIC vector containing kanamycin resistance.  
All plasmids were transformed into DH5α cells, selected with the appropriate antibiotic, mini-
prepped, and sequenced to confirm the presence of the correct insert.  All three plasmids were 
then co-transformed into BL21* cells and grown on ampicillin, tetracycline, and kanamycin 
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triple selection plates. 
 The remaining exosome plasmids (Rrp44 and Csl4) were constructed by Fran Ding.  The 
gene for full length wildtype Rrp44 was inserted into a hexahistidine pLIC vector with a 
kanamycin selection marker, and Rrp44 mutants (D551N, D171N, or D551N-D171N) were 
created by site directed mutagenesis of the wildtype plasmid.  Csl4 was inserted into a pET23a 
vector containing an N-terminal hexahistidine tag and ampicillin selection marker.  Both 
plasmids were prepared using standard procedures and confirmed by DNA sequencing.   
Protein Expression and Purification 
Cultures containing recombinant exosomes were grown in 4.5 L of LB supplemented with 
concentrations of 5 µg/mL tetracycline, 100 µg/mL ampicillin, and 50 µg/mL kanamycin in a 
shaker at 37 °C and 200 rpm until reaching an OD600 of ~1.  They were then induced with 1 mM 
IPTG and incubated overnight at 18 °C and 200 rpm.  Cells were then pelleted and resuspended 
in Buffer A (20 mM Tris pH 7.5, 300 mM NaCl, 10 mM Imidazole, 5 mM betamercaptoethanol, 
10% glycerol, and 1 mM PMSF) and were lysed by sonication.  Purification was completed 
using Ni-NTA chromatography.  Supernatant was applyed to the resin, washed with 10 column 
volumes of Buffer A containing 20 mM imidazole, and eluted with Buffer A containing 300 mM 
imidazole.  The complex was then dialyzed into 20 mM Tris pH 7.5, 75 mM NaCl, 5 mM 
betamercaptoethanol, and 10% glycerol overnight, and run on MonoQ using the same buffer and 
eluted with an increasing NaCl gradient.  Typical purifications of the recombinant exosome 
resulted in two nearly overlapping peaks (Fig. 3-3A).  Closer analysis revealed that the first of 
these peaks contained exosomes lacking subunit Rrp43, while the second peak contained 
complete exosomes.  Only peaks containing complete exosomes were pooled and concentrated. 
 Full length wild type Rrp44 and mutants as well as Csl4 were grown in 4.5 L of LB  
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Figure 3-2. Summary of the co-expression strategy used to purify recombinant exosomes.  
Plasmids on the left were co-expressed under triple antibiotic selection, while those on the right 
were expressed separately and then mixed with the co-expressed proteins. 
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supplemented with the appropriate antibiotic, and expressed and purified in a similar fashion as 
for the exosome, and concentrated.  The partially assembled exosome was then mixed in a 
1:1.5:1 molar ratio with Csl4 and Rrp44 (wild type or mutant), incubated on ice, and separated 
on a Superose 6 column equilibrated with 20 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol, and 
1 mM DTT.  The complex eluted as a single peak (Fig. 3-3B), which appeared to contain all 
exosome subunits (Fig. 3-3C). 
3.2.2. Results 
Recombinant exosomes were intended for EM analysis and biochemical assays.  Despite 
appearing to assemble well during size exclusion chromatography, upon EM analysis exosomes 
were revealed to be poorly assembled (19).  Subsequent collaborative single molecule studies 
also indicated that the recombinant exosomes lacked activity (20).  Therefore, it appears that 
recombinant co-expression is ineffective in producing well assembled exosomes.  It is likely that 
not all subunits express to the same extent, and thus some subunits may remain 
substoichiometric in the complex, which could cause poor assembly and lack of activity.  In 
particular, difficulty occurs with producing a stoichiometric level of Rrp43.  It was suggested 
that the binding partner of Rrp43, Rrp46, undergoes degradation during purification but still 
binds to Rrp43, yet does not associate into exosomes (17).  This would explain why onlyhalf the 
yield of the exosomes contain Rrp43.  However, the exact reason for poor assembly and lack of 
activity is unknown.  Although our failure to produce quality recombinant exosomes sheds some 
doubt on other studies conducted with recombinantly purified exosomes (2, 16), the problems 
may be limited to our co-expression procedure and thus may not reflect the quality of exosomes 
purified by other methods. 
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Fig 3-3. Purification of Recombinant Exosomes. A) MonoQ purification of recombinant 
exosomes resulted in two overlapping peaks, the first of which lacked subunit Rrp43.  B) Size 
exclusion chromatography profile of Rrp44 containing recombinant exosomes run on a Superose 
6 column.  C) SDS-PAGE analysis of Rrp44 containing exosomes after size exclusion 
chromatography purification.  The asterisk indicates a contaminating band that likely represents 
a truncation of Rrp44. 
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3.3. TAP purification of yeast exosomes 
 
Since recombinant purification methods were unsuccessful, we instead purified exosomes from 
yeast cells using a Tandem Affinity Purificaiton (TAP) procedure (21), performed according to 
the following methods.  
 
3.3.1. Methods 
Yeast Culture Growth 
A S. cerevisiae yeast strain containing a TAP tag on Rrp46 and a deletion for the nuclear 
exosome cofactor Rrp6 was kindly provided by J. Scott Butler of the University of Rochester 
Medical Center.  A glycerol stock of the strain was streaked onto a YPD plate and grown 
overnight at 30 °C.  A single colony was picked from the plate and inoculated into 200 mL of 
YPD media (10 g yeast extract, 20 g bacto-peptone, and 50 mg of adenine sulfate per liter) 
supplemented with 10 µg/mL of tetracycline, and grown for about 48 hours at 30 °C with 
shaking at 200 rpm.  An amount of 16 mL of starter culture was then diluted into a total of 12 L 
of YPD media of yeast, supplemented with 4% glucose, and then grown at 30 °C for about 20 
hours, or until the OD600 reached 6-10.  At this point, the cultures were supplemented with 150 
mL of 40% glucose and 37.5 mL of 4 g/L adenine sulfate.  Flasks were shaken for another 6 
hours until reaching a saturating OD600 of about 12-13 and then pelleted by centrifugation.  A 
typical yield was about 450 g of cell paste.  Cells were resuspended in 5X Lysis Buffer (250 mM  
Tris-HCl pH 7.38, 150 mM NaCl, 5 mM EDTA, 50% glycerol, 5% DMSO, and 50 µM ZnCl2), 
supplemented with 5 mL of 100X complete protease inhibitors (17 mg PMSF, 28.5 µg leupeptin, 
137 µg pepstatin A, and 33 mg benezamidine per mL dissolved in 100% ethanol), and flash  
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Figure 3-4. Cartoon representation of the TAP Purification of the Yeast Exosome.  The 
straightforward procedure on the far left was used to purify exosomes containing wildtype 
Rrp44, while washing with 1.2 M MgCl2 and subsequent application of mutant recombinant 
Rrp44 was used to purify mutant exsomes.  All exosomes were polished with a MonoQ step, 
which removed contaminating proteins and all RNA (depicted as wavy lines). 
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frozen in 50 mL aliquots for storage at -80 °C.   
TAP purification 
For purification, cell pellets were thawed and solid NaCl was added to a final concentration of 
150 mM. Cells were also supplemented with 5 mL of 100X protease inhibitors and 500 µL of 1 
mg/mL DNase I solution.  Cell disruption was completed by beating cells with silicon beads in 
two bead beaters for 1 hour at 4 °C.  Bead beaters were submerged in an ice bath created by 
mixing ice with drive-way salt (IceMelt) to maintain a temperature of -10 °C to prevent protein 
denaturation from excessive heat released during cell breakage.  Beads were removed by 
filtration, and lysate was centrifuged in an ultracentrifuge at 35,000 rpm for 1 hour.  The TAP 
purification of all exosomes was completed as represented in Fig. 3-4.  The supernatant was 
filtered and loaded onto 3 mL of IgG resin (Sigma-Aldrich) equilibrated in 1X lysis buffer (50 
mM Tris-HCl pH 7.38, 30 mM NaCl, 1 mM EDTA, 10% glycerol, 1% DMSO, and 10 µM 
ZnCl2) at a flow rate of about 1 mL/minute at 4 °C.  After loading, the resin was washed with 50 
mL of 1X lysis buffer containing 500 mM NaCl, and then equilibrated into TEV cleavage buffer 
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 µM ZnCl2, 20% glycerol, 0.5 mM EDTA, 2 mM 
EGTA, 1 mM DTT, and 0.5 mM PMSF).  Exosomes were cleaved from the resin by application 
of 100 µL of 1 mg/mL TEV protease followed by incubation of 1 hour at 4 °C.  Normally, three 
rounds of cleavage were sufficient to completely remove the complex from the resin.  Elutions 
were analyzed by SDS-PAGE, and then pooled and dialyzed overnight at 4 °C into 20 mM Tris 
pH 8.0, 20% glycerol, and 1 mM DTT.  Protein was loaded onto a 1 mL MonoQ column and run 
in the same buffer, and eluted with an increasing gradient of NaCl.  Peak fractions were analyzed 
by SDS-PAGE (Fig. 3-5A).  Peak fractions were concentrated and flash frozen in liquid nitrogen 
and stored at -80 °C until use. 
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Preparation of Mutant Rrp44 Exosomes 
To reconstitute exosomes with mutant Rrp44, wild type exosomes were prepared from yeast in a 
similar manner, but the resin was additionally washed with 40 mL of 1X lysis buffer containing 
1.2 M MgCl2., which was adjusted with 1M Tris to a pH of 7.38 to prevent a decrease in pH from 
the addition of magnesium, which could result in proteins leaching from the column.  This wash 
step efficiently removed endogenous wildtype Rrp44 from the exosome complex (Fig. 3-5B).  
Core exosomes were then cleaved with TEV protease, dialyzed into low salt buffer, pooled and 
concentrated.  Core exosomes were mixed with recombinant mutant Rrp44 (D551N, D171N, or 
D551N-D171N) in about a 1:1.5 molar ratio, incubated for 3 hours at 4 °C, and separated on a 1 
mL MonoQ column in buffer containing 20 mM Tris pH 8.0, 20% glycerol, 1 mM DTT, and 
eluted using an increasing NaCl gradient.  Excess Rrp44 eluted at about 200 mM NaCl, while 
exosome complexes eluted at 300 – 350 mM NaCl (Fig. 3-5C). 
 
3.3.2. Results 
Wild-type yeast purified exosome were well assembled as judged by SDS-PAGE (Fig. 3-5) and 
were active in biochemical assays (sections 3.4-3.6), and for EM (19) and single molecule (20) 
studies.  Exosomes containing mutated Rrp44 lacked any wild-type activity (sections 3.4 and 
3.6), indicating that no free Rrp44 was carried over from purification.  Overall, the methods 
detailed in this section were successful for producing quality exosomes for analysis.      
 
3.4. Biochemical assays using mutant Hepatitis Delta Virus ribozyme substrates 
 
Initial studies used the Hepatitis Delta Virus (HDV) ribozyme.  The HDV ribozyme is a self 
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cleaving ribozyme that catalyzes site specific cleavage in the hepatitis delta virus (22, 23).  
Crystal structures of the wildtype (24) and mutant (25, 26) ribozyme indicate that it forms a 
stable three dimensional structure, and thus for our purposes it serves as a model structured RNA 
substrate. 
 
3.4.1. Methods 
Hepatitis Delta Virus ribozyme RNA Preparation 
RNA substrates were engineered to contain a U1A protein binding loop and designed to contain 
a 3’ end tail of 0 – 80 nucleotides consisting mostly of adenines, with one uridine placed between 
a length of ~4-5 adenines.  Additionally, the template contains a C75U mutation to render the 
ribozyme catalytically inactive.  All substrates were prepared by in vitro transcription using T7 
RNA polymerase as follows.  A 3 mL transcription reaction was preformed for each substrate 
using 150 µg of DNA template, 500 µL of recombinant T7 RNA polymerase diluted 1:20, 150 
µL each of 100 mM ATP, UTP, GTP, and CTP; 30 mM Tris pH 8.1, 10 mM DTT, 25 mM 
magnesium acetate, 2 mM spermidine, 0.01% TritonX100, and diluted up to 3 mL with 
deionized water.  The reactions were incubated for 6 hours at 37 °C, mixed with an equal volume 
of 2X RNA loading dye (95% formamide, 0.025% bromophenol blue, 0.025% xylene cyanol FF, 
and 10 mM EDTA), and purified on 10% polyacrylamide/8 M urea gels.  RNA was visualized 
with UV shadowing.  The RNA was excised from the gel, the gel piece was crushed, and RNA 
was eluted in nuclease free deionized water at 4 °C overnight.  Substrates were dephosphorylated 
with FastAP Alkaline Phosphotase (Fermentas), and extracted twice with Tris saturated phenol 
and once with chloroform to remove all traces of enzyme.  RNA was then ethanol precipitated 
with 50 mM NaCl, 80% ethanol, and 2 µL glycoBlue (Ambion) at 4 °C.  RNA was centrifuged 
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Figure 3-5. SDS-PAGE analysis of yeast purified wildtype and mutant exosomes.  A) TAP 
purification of wildtype exosomes followed by MonoQ polishing.  Note that the asterisk 
represents Ski7, which is present in the cytoplasmic exosome and substoichiometric in all 
purifications.  It is not a nuclease and does not affect subsequent assays.  B) Removal of Rrp44 
after washing with 1.2 M MgCl2.  C) Reconstitution of the core exosome with mutant Rrp44 
after MonoQ purification.  Shown is the reconstitution with Rrp44 D551N.  Free Rrp44 elutes 
early in the run (~200 mM NaCl), while the Rrp44 bound exosome elutes later (~300 – 350 mM 
NaCl), indicating that exosome are not contaminated with free Rrp44.  
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for 30 minutes at 13,200 rpm, ethanol was decanted, and RNA pellets were dissolved in 30 µL of 
nuclease free water.  RNA was then 5’ end labeled using polynucleotide kinase and 2 µL of 3000 
Ci/mmol 
32ɣP-ATP (Perkin Elmer), purified on 10% polyacrylamide/8 M, and eluted and ethanol 
precipitated in a similar manner as mentioned earlier.  RNA pellets were washed with 80% 
ethanol, air dried, and dissolved in a final volume of 30 µL nuclease free water, and stored at -20 
°C until use.  
RNA Refolding 
Directly before conducting activity assays, RNA was refolded in 20 mM HEPES pH 7.5, 100 
mM NaCl, 200 μM MgCl2 by heating  to 80 °C for 5 minutes followed by snap cooling at 4 °C.  
All refolded substrates appeared to migrate as a single species when analyzed 8% native 
acrylamide/2.5 mM magnesium acetate gels (not shown). 
RNase Assay 
For exonuclease assays, RNA was freshly refolded and diluted to reduce the magnesium 
concentration to 100 μM.  Enzyme was added and incubated in a time course at 30 °C.  For time 
course assays, concentrations of 100 nM enzyme and 100 nM substrate were used.  For 
endonuclease assays using Rrp44 D551N, MnCl2 was added at a concentration of 3 mM after 
refolding, since heating RNA in high manganese otherwise results in RNA backbone cleavage.  
Reactions were stopped by the addition of 2X RNA loading dye, heated for 10 minutes at 65 °C, 
and loaded onto 12-16% Acrylamide Urea Sequencing Gels (National Diagnostics).  
Radioactivity was detected using with a phosphostorage screen, and developed using a 
phosphoimager (Typhoon, Amersham). 
Hydroxyl radical (OH) RNA ladders were creating by incubating RNA with an equal 
volume of buffer containing 100 mM sodium bicarbonate pH 9.0 and 2 mM EDTA at 80 °C for 5 
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minutes.  RNase T1 ladders were produced by incubating 10
-2
 units/µL of RNase T1 with RNA 
in buffer containing 20 mM sodium citrate pH 3.5, 1 mM EDTA, 50 mM NaCl, and 7 M urea at 
50 °C for 15 minutes, followed by extracting twice with Tris saturated phenol, once with 
chloroform, and precipitating with ethanol.   
 
3.4.2. Results 
Initial assays were conducted by incubating 100 nM of Rrp44 or TAP purified exosome with 100 
nM of various RNA substrates in buffer containing 100 μM MgCl2 at 30 °C.  Somewhat 
surprisingly, HDVs with 3’ end tails of 0, 8, 20, 30, 40 and 80 nucleotides all produced identical 
intermediates and end products regardless of tail length (Fig. 3-6A).  For reactions with Rrp44, 
an incomplete digestion occurs, producing an intermediate of ~41 nt as well as end products of 
4-5 nucleotides for all HDV substrates tested.  Using 5 – 10 fold more Rrp44 resulted in an 
almost complete digestion of the test HDV40 substrate and a larger accumulation of 
intermediates and end products compared to the former assay (Fig. 3-7A).  Digestion of the 
HDVs with the Rrp44-bound exosome appears to proceed at a comparable rate and results in the 
accumulation of both the ~41 nucleotide intermediate as well as end products, but also produces 
an additional intermediate at ~65 nucleotides, which represents the size of the HDV that has had 
the 3’ end tail removed.  A titration of exosome concentration indicated that even 10 fold more 
exosome than substrate still resulted in an incomplete reaction (Fig.3-7A).  A time course 
degradation of the exosome at various temperatures using HDV80 as a substrate revealed that at 
even 4 °C, the 3’ end tail is removed within a matter of minutes, while the other intermediate and 
end products are produced slower (Fig. 3-7B).    
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Figure 3-6. Degradation Assay of HDV 3’ end extensions with wildtype Rrp44 and wildtype 
Rrp44 bound exosome.  The mutant HDV is degraded by Rrp44 or the exosome in the same 
manner regardless of 3’ end tail length.  A) Degradation assays with Rrp44 and the exosome on 
HDV substrates with 3’ end tail lengths of 0 – 80 nucleotides.  B) Cartoon representation of the 
secondary structure of the HDV ribozyme.  Vertical dashes represent Watson-Crick base pairs 
and ovals represent wobble base pairs.  The normal HDV cleavage site is marked with a 
lightning bolt, and the mutated catalytic residue is circled.  Red arrows mark sites of 
intermediates for Rrp44 and/or exosome mediated degradation. C) Mutational studies of Rrp44 
and exosome mediated degradation using HDV30 as a model substrate. 
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To test whether the RNase activity of Rrp44 and the exosome occurred via an exo or  
endonucleic pathway, mutations were made in Rrp44 in the exonuclease site (D551N, ex), 
endonuclease site (D171N, en), or both sites (D551N-D171N, dm) and HDV40 was assayed 
under the same conditions as tested previously using both Rrp44 and the exosome.  Both  
wild-type Rrp44 and the exosome, as well as the endo mutants, degraded the RNA 
predominantly by the exonucleic pathway under Mg
2+
 conditions, while the exo and double 
mutants had no activity (Fig. 3-6C).  Thus, the results of this study indicate that Rrp44 alone has 
the ability to unwind and degrade even highly structured RNA via its exonuclease activity under 
concentrations of low magnesium.  The Rrp44 bound exosome displays a similar cleavage 
pattern, yet degradation is impeded and never goes to completion.  This indicates that the bound 
exosome core partially prevents Rrp44 from degrading through the entire substrate.  
To investigate how Rrp44 and the exosome deal with ―roadblocks‖ such as bound proteins 
during degradation, a degradation assay was conducted in the presence of a titration of the U1A 
protein, which binds to an engineered site on the HDV substrate (Fig. 3-6B).  HDV was 
incubated with increasing amounts of U1A for 30 minutes on ice before the addition of either 
Rrp44 or the Rrp44 bound exosome, and then incubated at 30 °C for 90 minutes.  U1A binding 
effectively impedes degradation, most notably for the exosome, which had a dramatic reduction 
of both intermediates and end products under high U1A concentrations (Fig. 3-8A).  
Interestingly, high concentrations of U1A also appear to halt Rrp44 from degrading into the 
interior of HDV, and produce a first intermediate of ~65 nt that runs at the same relative position 
as the intermediate originally produced only during exosome mediated degradation (Fig. 3-8A).   
 
 
111 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-7.  Degradation of mutant HDV substrates at various temperatures and protein 
concentrations. A) Degradation assay of HDV40 using a titration of 10 nM – 1 µM of either 
Rrp44 or exosome.  B) Degradation assay of HDV80 performed at the various temperatures 
indicated.  
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Since the U1A binding loop on HDV lies between the sites of the two intermediates (Fig. 
3-6B, nucleotides 48 – 57), it appears that steric hindrance upon U1A binding partially impedes 
Rrp44 from degrading the HDV past the U1A binding site.  The more dramatic reduction in 
activity witnessed when using the exosome indicates a possible regulatory role of the core 
exosome in allowing for the degradation of accessible 3’ ends of substrates, yet preventing 
degradation into regions of RNA bound by proteins.  It is therefore likely that physiological  
exosome substrates that form ribonucleoprotein particles like snoRNAs are prevented from being 
completely degraded during maturation by the exosome by the assistance of bound proteins that 
block the exosome from degrading past a certain region.  
It has previously been reported that the Rrp44 bound exosome is optimally active at 
concentrations of ~100 µM MgCl2, yet inhibited at concentrations of 5 mM MgCl2, which is a bit 
odd considering than many other nucleases are active in these conditions including Rrp6 (16) and 
that many structured RNA would not be completely folded in these concentrations.  To 
investigate the effect of magnesium concentration on the activity of the exosome, we conducted 
degradation assays with HDV40 using a titration of magnesium.  Similar to reports by other 
groups with different substrates (27), degradation activity of Rrp44 was only slightly reduced at 
5 mM MgCl2 for HDV40, while the exosome was inhibited to a greater extent (Fig. 3-8B).  Since 
the HDV requires divalent cations for proper folding, it was possible that a lower concentration 
of magnesium resulted in improper folding and thus a greater likelihood that the exosome could 
degrade the substrate.  Therefore, a more detailed magnesium titration degradation analysis was 
conducted with several HDV substrates that were refolded and then diluted two fold to produce 
MgCl2 concentrations of 100 µM, 1 mM, and 2.5 mM.  RNA was then incubated with either 
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Figure 3-8. Activity Studies with Rrp44 and the Exosome. A) U1A blocking assay on the 
HDV substrate.  U1A was titrated at concentrations of 0, 0.1, 0.2, 0.4, 0.6, 0.8, 1, and 1.2 µM.  
The degradation assay was then run with either Rrp44 or the exosome.  B) MgCl2 concentration 
gradient.  Degradation assays were run with either 0.05, 0.10, 0.50, 1, 5, or 10 µM, or in the 
presence of 10 mM EDTA (indicated as ―E‖).  ―R‖ represents RNA only lanes, and ―OH‖ is the 
hydroxyl radical ladder. 
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Figure 3-9. A high concentration of magnesium causes the exosome to degrade the 3’ end of 
substrates more specifically, but not Rrp44.  HDV, HDV8, and HDV40 was assayed for 
degradation by either Rrp44 or the exosome in the concentrations of MgCl2 indicated.  At high 
magnesium concentrations, the exosome degraded more specifically around the 3’ end of the 
substrate, but minimal change was seen for Rrp44 alone. 
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Rrp44 or Rrp44 bound exosome in an over-digestion of 150 minutes at 30 °C.  While no distinct 
inhibition of Rrp44 alone was displayed at these magnesium concentrations, the activity of the 
Rrp44 bound exosome appeared inhibited at concentrations over 1 mM (Fig. 3-9).  At 2.5 mM 
MgCl2, the HDV and HDV8 substrates were almost completely protected from degradation by 
the exosome while assays with HDV40 at this concentration produce a noticeable reduction of 
end products and accumulation of secondary intermediates near the 3’ end of the substrate.  For 
these particular substrates, the results suggest that the reduction in degradation of the structured 
region of the HDV could be due to better folding at higher magnesium concentrations.  However, 
previous reports indicate that the degradation by the exosome on single stranded RNA substrates 
is also inhibited in high magnesium concentrations (27), indicating that inhibition at very high 
magnesium concentrations is not due to structural hindrance by the RNA alone.  Therefore, it is 
likely that in a physiological setting the exosome is selectively active on single stranded regions 
at concentrations less than 5 mM but much higher than 100 µM, since at lower concentrations 
Rrp44 can promiscuously degrade into structured regions as well.   
In order to determine the possibility of a direct access route of degradation by the 
exosome, it was necessary to test whether the PIN domain of Rrp44 was catalytically active 
while Rrp44 was bound to the exosome.  The endonuclease activities of Rrp44 and the exosome 
were tested with the exonuclease mutant Rrp44 (D551N) by conducting assays with 3 mM 
MnCl2 using select RNA substrates.  While HDV80, which has a very long 3’ end tail, was 
degraded by both Rrp44 and to a lesser extent by the exosome, HDV—no 3’ tail—produced faint 
degradation products that mapped to the 5’ leader sequence with Rrp44 but no degradation 
products with the exosome (Fig. 3-10A).  This indicates that the PIN domain of Rrp44 is active 
when bound to the exosome, which agrees with previous results from the Conti group (2).   
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Figure 3-10. Endonuclease activity of Rrp44 D551N and the Rrp44 D551N exosome. A) 
Time course of HDV and HDV80 in buffer containing 3 mM MnCl2.  B) Protein titration on 
HDV40.  Substrate was incubated with a concentration of 10, 100, 500, or 1000 nM of either 
Rrp44 D551N or the Rrp44 D551N exosome for 90 minutes. C) Manganese titration.  Reactions 
were run a gradient of 0.5, 1, 3,  5, or 10 mM MnCl2, or with 25 mM EDTA (lanes labeled with 
―E‖). 
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Furthermore, higher protein concentrations resulted in more pronounced endonuclease 
degradation by Rrp44, but little change for the Rrp44 bound exosome on HDV40 (Fig. 3-10B). 
Specifically, Rrp44 appeared to robustly degrade regions in both the single stranded 3’ end tail 
and 5’ end leader sequence at high enzyme concentrations, while also showing some degradation  
at and around single stranded regions, which agrees with previous results (7).  Much less activity 
was observed for the Rrp44 exosome, which almost exclusively degraded the 3’ tail of HDV40, 
and to a far lesser extent the 5’ leader.  Unlike the inhibitory effects of high levels of magnesium 
on the Rrp44 bound exosome (Fig. 3-8B, Fig. 3-9), both Rrp44 and the Rrp44 bound exosome 
displayed an almost flat activity profile in manganese concentrations ranging from 1 – 10 mM 
(Fig. 3-10C).   
When the results of the endonuclease assays are taken together, they suggest that long single 
stranded regions of RNA are most susceptible to endonuclease attack by the PIN domain of free 
Rrp44, while short loops, such as those contained HDV, are resistant to attack, and double 
stranded regions are protected.  Moreover, the exosome core appears to regulate the 
endonuclease activity of the PIN domain of Rrp44, allowing it to degrade exposed single 
stranded regions of the RNA, while preventing it from degrading into structured regions and 
internal loops.   
 
3.5. Degradation of wildtype HDV RNA substrates by Rrp44 and the exosome 
 
Since both Rrp44 and the exosome were shown to degrade into the structured region of 
the mutated HDV ribozyme, we suspected that such degradation may arise from slight flexibility 
of the HDV ribozyme, possibly due to the addition of the leader that was appended to the 5’ end  
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Figure 3-11. Degradation assays with wild-type HDV.  Concentrations of 200 nM of RNA 
were incubated with either 400 nM or Rrp44 (labeled ―44‖), or 400 nM (―Ex1‖) or 1 µM (―Ex2‖) 
exosome.  ―R‖ is the RNA only lane. 
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of the substrates to allow for efficient radio-labeling.  Therefore, to ensure that our results were 
accurate, we decided to test degradation using a wildtype version of the HDV ribozyme.  Since 
the previous assays with mutant HDV ribozyme indicated that the exosome selectively degraded 
single stranded 3’ ends at higher magnesium concentrations, a MgCl2 concentration of 500 µM 
was used in the following assays.        
 
3.5.1. Methods 
Wildtype HDV in-vitro transcription 
5’ end labeling of the native HDV is difficult since the 5’ end of the RNA is buried inside the                  
structure when folded (24).  Therefore, we instead body labeled the substrates during in vitro  
transcription.  Small scale (500 µL) transcription was conducted in a manner similar to that 
described previously, but in the presence of 5 µL of 3000 Ci/mmol α-32P-CTP.  Transcription 
products were then concentrated to a volume of 40 µL using mini 10 kDa cut-off spin column 
concentrators.  To allow for native purification, 20 µL of 60% glycerol was added to the samples 
before they were loaded onto a native 8% acrylamide gel containing 2.5 mM magnesium acetate 
and run at 600 volts for 2 hours at 4 °C.  RNA was visualized by UV shadowing, and substrates 
were excised and eluted overnight into 20 mM Tris pH 7.5, 50 mM NaCl, and 2 mM MgCl2 at 4 
°C.  Samples were then concentrated and stored at -20 °C until use. 
RNase Assays 
Assays were performed in buffer containing 10 mM HEPES pH 7.5, 50 mM NaCl with a final 
MgCl2 concentration of 500 µM, and used a concentration of 200 nM of RNA.  Rrp44 was 
assayed at 400 nM, and yeast exosome at concentrations of both 400 nM and 1 µM.  Mixtures 
were incubated at 30 °C for 90 minutes and then diluted up to 100 µL with reaction buffer and 
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extracted with an equal volume of Tris saturated phenol.  Samples were then precipitated by the 
addition of 450 µL of 100% ethanol and 1 µL of GlycoBlue.  Samples were incubated on ice for 
30 minutes, centrifuged for 30 minutes at 13,200 rpm, decanted, air dried, and dissolved in 5 µL 
of 2X RNA loading dye.  RNA was then heated at 65 °C for 10 minutes and loaded onto a 12% 
acrylamide/8 M Urea sequencing gel. 
 
3.5.2. Results 
The results are what would be expected of a direct access pathway of RNA degradation by the 
exosome for a more structured RNA substrate.  In contrast to the mutant version, the wildtype 
HDV lacking a 3’ end extension is not degraded by either Rrp44 or the exosome (Fig. 3-11). 
Likewise, the 3’ end tail of the HDV8 can be removed by Rrp44 but not by the exosome.  
However, 3’ end extensions of 20 nucleotides or longer can be removed by either Rrp44 or by 
the exosome.  As noticed earlier with the mutant HDV, exosome mediated degradation is less 
efficient than degradation by Rrp44 and never goes to completion.  There is also a lack of any 
other stable intermediates or end products in this reaction, indicating the wildtype HDV appears 
more stable towards exonuclease attack than the mutant version.   
 
3.6. Degradation of hypomodified tRNA by Rrp44 and the exosome 
 
Since the degradation pattern of the wildtype HDV differed from that of the mutant HDV, a 
degradation study was conducted using yeast initiator methinone tRNA from yeast, which has 
been indicated as a physiological substrate of the Rrp44 bound exosome (13).  Physiological 
eukaryotic tRNAs contain numerous posttranscriptional modifications such as the addition of a 
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non-template 3’ end CCA tail, as well as methylation of guanine and adenine bases and 
pseudouridination.  The tRNAs used in this study are produced by in vitro transcription and have 
an appended CCA tail, but lack all other posttranscriptional modifications.  Substrates were 
designed to include an additional, poly-adenine 3’ end tail of various lengths between 0 – 37 
nucleotides. 
 
3.6.1. Methods 
Cloning, DNA isolation, and plasmid linearization 
Initiator methionine tRNA substrates were created with 3’ end extensions of 0, 6, 10, 20, 30, and 
37 adenines.  The tRNA inserts were PCR amplified using overlapping primers, with a 5’ primer 
containing an EcoRI site followed by a phage T7 transcription start site.  Inserts were then 
cleaved with EcoRI and inserted into a modified pUC19 vector that was linearized with EcoRI 
and SmaI, and then treated with polynucleotide kinase, followed by T4 DNA ligase treatment.  
The ligation mix was then transformed into DH5α cells, and grown on ampicillin selective LB 
plates.  The pUC19 vector contains the wildtype HDV sequence at the 3’ flanking end of the 
insert, and is used in order to produce a homogenous 3’ end on the transcript, since T7 RNA 
polymerase has the tendency to add a few non-templated nucleotides on the 3’ end of the 
transcript (28).  
 Initially, DNA was isolated using miniprep and sequenced to confirm the presence of the 
correct insert.  Correct inserts were then subsequently grown in larger volume cultures for either 
midi-prep or mega-prep DNA isolation, following the manufacturer’s instructions (Qiagen).  
Plasmids were then linearized with either HindIII or BamHI overnight at 37 °C and ethanol 
precipitated. 
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In vitro Transcription and radiolabeling 
Transcription was completed as described previously (section 3.4.1) using 10 mL reaction 
volumes for the tRNA without 3’ extension and the 6 nucleotide extension, and 1 mL volumes 
for the rest of the substrates.  Samples were then heated at 65 °C for 20 minutes to allow the 
HDV to completely cleave to produce a homogeneous 3’ end on the tRNA substrate.  Substrates 
were purified by PAGE, eluted, and concentrated as described previously.  Fast AP alkaline 
phosphate was used to remove the 5’ end triphosphate as well as the 3’ end cyclic phosphate 
created by HDV cleavage.  Samples were extracted, ethanol precipitated, and 5’ end radiolabeled 
as described previously (section 3.4.1).  In general, most substrates were labeled efficiently, with 
the exception of tRNA10 and 20, which were poorly labeled for an unknown reason, despite the 
fact that all substrates were labeled following the same protocol. 
RNase Assays 
Initial exonuclease assay conditions were similar to those of the mutant HDVs.  RNA was 
freshly refolded in buffer containing 20 mM HEPES pH 7.5, 100 mM NaCl, and between 200 
µM and 20 mM MgCl2 by heating to 80 °C for 5 minutes, followed by snap cooling to 4 °C.   
Initial assays utilized ~100 nM of RNA and 100 nM of enzyme in buffer containing 100 µM of 
MgCl2, and degradation was tested in a time course during incubation at 30 °C.  In further 
studies, magnesium concentrations between 100 µM - 10 mM, and protein concentrations from 
200 nM – 2 µM were tested.    Mutational studies were conducted with 200 nM of RNA, 400 nM 
of protein, and 1 mM MgCl2, and incubated for 90 minutes at 30 °C.  Endonuclease studies were 
conducted in a similar manner but with the inclusion of 3 mM MnCl2.  All reactions were 
quenched by the addition of 0.5 µL of 10% SDS, 0.5 µL of 500 mM EDTA, and 1 µL of 14 
mg/mL Proteinase K, and incubated and 37 °C for 30 minutes to remove all traces of protein.   
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Figure 3-12. Degradation of tRNA by Rrp44 and the Rrp44 bound exosome. A) Degradation 
of tRNA and tRNA37 in 100 mM MgCl2with Rrp44 and the exosome during a time course.  
Amounts of 100 nM of enzyme and 100 nM of RNA were used in this assay.  B) Degradation of 
tRNA and tRNA30 in a magnesium chloride titration.  Amounts of 200 nM substrate and 400 
nM enzyme were used.  MgCl2 concentration ranged from 100 nM to 10 mM.  Reactions were 
incubated for 90 minutes total.  ―Np‖ represents lanes with no protein.  
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Proteinase K treatment was essential to prevent band shifts which prominently appeared for 
reactions containing yeast exosomes.  An amount of 2-3 µL of 2X RNA loading dye was then 
added to the aliquots, and they were heated at 65 °C for 10 minutes.  Approximately equal 
amounts of radioactivity were loaded onto 12% acrylamide/urea sequencing gels, and run at 
1200 V, 300 mA, and 50 W for about 2 hours.  Radioactivity signal was detected with a 
phosphostorage screen, and visualized with a Typhoon phosphoimager. 
 
3.6.2. Results  
Compared to the HDV substrate, the tRNA substrate without a 3’ tail was degraded relatively 
poorly by both free Rrp44 and the exosome, producing only faint end products (Fig. 3-12A).  
However, degradation of tRNA37 with both Rrp44 and the exosome did produce an intermediate 
the same size of the tRNA CCA substrate, suggesting selective removal of its 3’ end tail (Fig. 3- 
11A).  To thoroughly test the effect of magnesium on degradation, a magnesium titration assay 
was conducted.  In general, tRNA appeared more stable than wildtype HDV ribozyme at low 
magnesium.  The tRNA without a 3’ end overhang is only mildly susceptible to degradation by 
Rrp44 at MgCl2 concentrations of 100 µM – 1 mM, producing only faint end products (Fig. 3-
12B, right).  The exosome showed no activity towards this substrate, regardless of the 
magnesium concentration.  The magnesium concentration appeared less important for Rrp44 
mediated degradation of the longer tRNA30, producing a main intermediate and faint end 
products at almost all concentrations tested (Fig. 3-12B, left).  However, for exosome mediated 
activity, degradation down to the intermediate appeared optimal at 1 mM MgCl2, and was 
inhibited at concentrations above this level.  Overall, the exonuclease activity of Rrp44 appears 
relatively insensitive to the concentration of magnesium in the assay when degrading single  
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Figure 3-13.  Degradation of tRNA substrates by Rrp44 and the Rrp44 bound exosome.  A) 
Amounts of 200 nM of substrate and 400 nM of enzyme were used in assays containing 1 mM 
MgCl2 and incubated during a time course.  Lanes labeled as ―CCA‖ represent lanes in which 
tRNA containing only a 3’ CCA tail was loaded as a size marker.  B) Mutational studies on 
tRNA substrates.  C) Endonucleic tRNA cleavage by Rrp44 and the Rrp44 bound exosome.  
Assays were conducted with the tRNA without a 3’ end or tRNA37 in buffer containing 3 mM 
MnCl2 and incubated at 30 °C for a time course.  The leftmost lane in each gel represents the 
RNA only sample.  
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stranded polyadenine regions, yet is slightly impeded at higher magnesium concentrations when 
degrading structured regions.  We find that the optimal condition for selective 3’ end degradation 
by the exosome is about 1 mM MgCl2, which would explain why previous results conducted in 5 
mM MgCl2 did not result in degradation (16).    We therefore concluded that conditions of 1 mM 
MgCl2 were sufficient to conduct further degradation assays. 
Similar to titration experiments, time course assays indicate that the tRNA CCA substrate 
lacking a polyadenine 3’ end tail was not degraded by either Rrp44 or the exosome in reaction 
conditions containing 1 mM MgCl2.  However, substrates containing 3’ end tail lengths of 6 or 
10 nucleotides were degraded efficiently by Rrp44 down to a product that migrated to a position 
consistent with that of the tRNA without a 3’ end tail (Fig. 3-13A, compare to tRNA marker).  
Substrates with 3’ end tail lengths of 20, 30, and 37 nucleotides were also degraded to the tRNA 
position by Rrp44.  Notably, minor degradation end products were produced for some  
reactions—mainly those with Rrp44 alone—but they are far less intense than the stable 
intermediates, and may result from a small pool of RNA that remains poorly folded even after 
refolding, or prior degradation products that arose during labeling of the RNA.  Mutational 
studies using catalytically inactive Rrp44 or exosome indicated that degradation resulted mainly 
from exonuclease activity (Fig. 3-13B). 
Endonuclease assays conducted with tRNA substrates agreed well with studies with the 
mutant HDVs (section 3.4).  Assays with tRNA and tRNA37 indicated that Rrp44 robustly 
cleaved the 3’ end off of tRNA37, while refraining from cleaving into the interior of the 
substrate (Fig. 3-13C).  Endonuclease activity with the exosome was only apparent in long 3’ 
end overhang, and internal loops and structured regions appeared protected from degradation, 
which is consistent with results from the mutant HDV substrates.  Therefore, we can 
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conclusively state that the exosome modulates the ability of Rrp44 to selectively 
endonucleotically degrade long 3’ ends and avoid internal regions. 
 
3.7. Investigating the role of the PIN domain in RNA binding. 
 
While the PIN domain has an established role in endonuclease activity, it was also reported to be 
necessary for duplex unwinding of substrates with a short 3’ end overhang (3).  We investigated 
the role of the PIN domain in RNA binding using electrophoretic mobility shift assays (EMSA) 
using HDV and tRNA substrates. 
 
3.7.1. Methods 
Cloning and protein purification 
Rrp44 full length and mutants were prepared as described earlier (section 3.2.1).  Rrp44 242-
1001 (wildtype and exonuclease mutant) and 25-1001 endo-exo mutant were cloned into pET19b 
vectors by using NcoI and XhoI restriction sites.  These constructs were based on fragments of 
the protein that co-crystallized when bound to RNA (242-1001 (3)) or the Rrp41/45 exosome 
subunits (25-1001 (2)).  Proteins were purified by Ni-NTA and MonoQ chromatography.   
EMSA 
EMSA was performed by incubating 200 µM of RNA (mutant HDV or tRNA) with a titration 
(~50 nM – 2 µM) of Rrp44 242-1001 (Rrp44ΔPIN) exo mutant or 25-1001 endo-exo mutant, in 
buffer containing 10 mM HEPES pH 7.5, 5 mM magnesium acetate, 10% glycerol, and 1 mM 
DTT for ~3 hours at 4 °C.  Mixes were then resolved through 6% acrylamide gels containing 2.5 
mM magnesium acetate at 4 °C, and RNA was visualized by phosphoimaging. 
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3.7.2. Results 
Rrp44ΔPIN binds both HDV and tRNA weaker than Rrp44 25-1001, which contains an almost 
full length version of the protein (Fig. 3-14A).  This, the PIN domain clearly is involved in RNA 
binding.  For an unknown reason, the Rrp44ΔPIN/RNA complex shifts to a higher position than 
the Rrp44 25-1001 complex.  
 
3.8. Discussion 
 
The results of the biochemical assays indicate a clear inhibitory role of the core exosome on the 
activity of Rrp44 towards highly structured RNA substrates, as has been suggested by other 
groups who used more simple substrates.  The association of Rrp44 with the exosome appears to 
impede Rrp44 from cleaving into structured regions of RNA, yet still allows the enzyme to 
specifically degrade long unstructured 3’ ends using both exonuclease and endonuclease 
activities.  In our studies, it is interesting to note that the exonuclease activity of the Rrp44 bound 
exosome was at least partially active on all mutant HDV ribozyme substrates tested, despite the 
presence of short or no 3’ end tails on some substrates, which theoretically indicates that they  
should not be channeled through the exosome core based on results reported by the Conti group 
(2).  Our results indicate that magnesium concentration is critical in regulating the activity of the 
exosome.  At low magnesium concentration (~100 µM) all HDV ribozyme mutant substrates are 
partially degraded, suggesting that their 3’ ends are at least slightly unfolded, creating a handle 
for the exosome to attach to and degrade the substrate using the exonuclease activity of Rrp44.  
Higher concentrations of magnesium restrict degradation by the exosome to mainly to the 3’ end 
of the substrate, and are most prominent on substrates with a long overhang.  A similar, though  
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Figure 3-14.  The role of the PIN domain in RNA binding and Rrp44 activity.  EMSA assay 
with Rrp44ΔPIN and 25-1001 catalytically inactive mutants with mutant HDV and tRNA 
substrates.   
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less pronounced, effect occurs for tRNA substrates as well.  Therefore, it is likely that the 
physiological magnesium concentration required for optimal exosome activity is around 0.5 – 1 
mM magnesium.  Lower magnesium appears to result in more promiscuous degradation by 
Rrp44, but magnesium concentrations up to 5 mM appears to have little inhibitory effect on the 
activity of Rrp44.  The Rrp44 bound exosome, however, is greatly inhibited at this concentration. 
We note that results from degradation assays of mutated HDV ribozymes are not entirely 
consistent with other substrates tested.  Notably, the mutant HDV ribozyme substrates also 
contained a 5’ single stranded leader that was included to allow for efficient labeling, while the 
wildtype HDV ribozyme and tRNA had recessed, double stranded 5’ ends.  The 5’ leader could 
interfere with proper folding.  Therefore, it is possible that the 3’ ends of these substrates could 
be somewhat flexible, especially at low magnesium concentrations, and thus still be able to be 
channeled through the exosome despite the lack of a long enough 3’ end tail.  While assays 
conducted with these substrates in low magnesium result in more end products, it is quite 
unlikely that the substrates were unstructured enough to be channeled through the exoosme 
core—which can only accommodate single stranded RNA—given that prominent intermediates 
were produced during exonuclease activity.  Also, unlike the other substrates, intermediates were 
different for either Rrp44 or exosome mediated degradation, suggesting a slightly different 
mechanism, indicating that degradation of highly structured regions was partially blocked by the 
exosome.  Furthermore, endonuclease assays of mutant HDV ribozymes indicated that structured 
regions are more protected, and therefore it is not likely that these substrates are completely 
unfolded.  Also, while the contribution of the 5’ end of the substrate to degradation was initially 
believed to be minimal, its role has not been fully accessed.  This region is a target for 
endonuclease attack by Rrp44, so it is possible that the 5’ end could allow for an RNA binding 
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domain of Rrp44 to grip onto it to hold the substrate in place while exonuclease activity on the 3’ 
end occurs.    
In general, consistent results from the wildtype HDV ribozyme and tRNA degradation 
assays point towards a pathway in which structured substrates with 3’ end tail lengths of less 
than 20 nucleotides can be degraded by Rrp44 but not the exosome under optimal conditions.  
Notably, this length is 11-13 nucleotides shorter than the length of 31-33 nucleotides reported to 
be required to span from the opening of the exosome channel to the active site of Rrp44 (2).  
Previous protection assays indicate that the 3’ end of an entirely single stranded RNA of about 
20 nucleotides could travel through the exosome and reach into the active site of Rrp44, but the 
5’ end would be buried within the exosome channel near the exit site and it could not reach to the 
entry site of the exosome core (2).  Given this evidence and the fact that wildtype HDV ribozyme 
and tRNA substrates contain a highly structured core that remains intact, it seems unlikely that 
the 3’ end is being degraded by the ―through exosome‖ route.  It is more plausible that the RNA 
is instead being directly degraded by Rrp44, which requires only about 10-13 nucleotides to 
reach its active site.  One caveat of this direct access pathway appears to be that it still restricts 3’ 
end tails shorter than 20 nucleotides, indicating that the exosome impedes, yet does not 
completely block, direct access into the active site of Rrp44, which points towards another 
possible role of regulation of Rrp44 by the exosome core.  The fact that a length of ~20 
nucleotides on the 3’ end of the substrate is required for degradation by the exosome is also 
consistent with a report that showed that the Trf4 component of the TRAMP complex adds about 
an average of 16-19 nucleotides to hypomethylated tRNA before degradation, indicating a 
possible physiological relevance of our results (29). 
An inhibitory role of the exosome core on the exonuclease activity of Rrp44 on RNA has 
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been established previously (27), but our results also indicate regulation of the endonuclease 
activity of Rrp44 by the exosome core.  While Rrp44 appears to be able to endonucleolytically 
degrade single stranded regions within the interior of structured RNA substrates, the Rrp44 
bound exosome is mainly restricted to degrading the 3’ end overhang.  A likely location of the 
RNA substrate during degradation is hypothesized by molecular modeling.  A model produced 
when docking the crystal structure of the ternary complex of Rrp44/Rrp41/Rrp45 and the human 
exosome core into the EM envelope of the yeast exosome (Fig. 2-10) suggests that the PIN 
domain of Rrp44 would be solvent facing when bound to the exosome and likely inaccessible to 
a ―through exosome‖ RNA recruitment pathway.  Therefore, the 3’ end of the RNA appears to be 
positioned near the bottom of the exosome, which suggests that it is directly accessing Rrp44 and 
not being channeled through the exosome core.  The mechanism of regulation of the 
endonuclease activity of Rrp44 by the exosome, however, is unclear because the PIN domain 
active site does not appear to be blocked by the exosome core.  One mechanism that would be 
consistent with a role of the exosome in dual modulation of the exo- and endo activities of Rrp44 
could be explained by the conformational change that accompanies the exonuclease region of 
Rrp44 upon RNA binding as displayed in the EM reconstruction (Fig. 3-1A, right).  Such a 
conformational change could both restrict access of the RNA to the PIN domain and could put 
the RNB domain of Rrp44 in a position to access shorter 3’ ends of the substrate.  However, due 
to the low resolution of the current reconstruction, further structural studies will be required to 
test whether such a mechanism exists and how it occurs.  Our studies also show that the PIN 
domain is involved in RNA binding and suggest that it can bind of RNA with RNB domain.  
This points towards a role of regulation of Rrp44, but further studies will need to be conducted to 
determine whether a similar effect occurs when Rrp44 is bound to the exosome. 
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When taken together, our studies point towards a direct access route of exonuclease 
degradation by Rrp44 when it is bound to the exosome core.  The two possible routes of direct 
access routes to Rrp44 are the solvent exposed route based on the crystal structure of RNA 
bound to Rrp44ΔPIN (3) and the RNase II like pathway (4).  Of these two routes, the RNase II 
like pathway is most supported by our results for a number of reasons.  The first is that our 
results indicate that a 3’ end overhang of 20 nucleotides is required for degradation by the Rrp44 
exosome.  This nucleotide length requirement is more consistent with the RNase II pathway, 
which requires 13 nucleotides to reach the active site, than the solvent exposed pathway, which 
requires only 9 nucleotides to reach the active site.  While 3’ end overhang lengths of 9-10 
nucleotides are definitely not degraded by the exosome, it is possible that intermediate tail 
lengths of 13-18 nucleotides can be degraded (they have not yet been attempted) which could 
help to explain the current disparity between tail length requirements.  However, the fact that 
RNA both binds to and can be degraded by the endonuclease PIN domain of Rrp44 indicates that 
it can in fact be recruited to the N-terminal region of the enzyme, which is in closer proximity to 
the entrance of the RNase II like pathway than to the exonuclease solvent exposed pathway when 
Rrp44 is bound to the exosome, based on EM reconstruction and subsequent crystal structure 
docking.  Furthermore, RNA binding results in a conformational change around the RNase II like 
entrance pathway in the EM reconstruction.  Single molecule data also implicate CSD1 as being 
the main RNA binding domain involved in the helicase activity of Rrp44, and this domain forms 
part of the entrance pathway to the RNase II like pathway, yet has no known role in the solvent 
exposed pathway.  Future structural studies including cryo-EM reconstruction of the exosome 
bound to structured RNA as well as mutational studies of residues involved in the entrance site 
of both pathways will help to further characterize this mode of direct access Rrp44 mediated  
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Figure 3-15.  Model of RNase II like direct access pathway to Rrp44.  Right, The RNase II 
like pathway is indicated and the nucleotide length required to reach the active site (13 nt) is 
given, along with the nucleotide length (9 nt) required for the solvent based pathway.  The data 
presented here more conclusively supports the RNase II pathway, which is indicated by a dashed 
line.  Left, RNA can be endonucleically degraded by the PIN domain, which is close proximity to 
the entrance of the RNase II like direct access pathway. 
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degradation by the eukaryotic exosome.     
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Chapter 4: Structural Studies of the Nuclear Exosome 
 
 
Abstract 
 
This chapter is focused on structural studies of the nuclear exosome feature the nuclease Rrp6.  
The Rrp6 containing exosome was reconstituted and analyzed by EM reconstruction.  Although 
extra density appeared to be present for Rrp6 during 2D analysis, Rrp6 could not be located 
during 3D analysis, suggesting protein flexibility or dissociation.  Later work involved the 
nuclear RNA binding protein Rrp47, and attempts were made at crystallizing the protein alone or 
in complex with Rrp6.  While limited proteolysis was successful at producing crystals of Rrp47, 
no diffraction was obtained.  Continued efforts will focus on engineering Rrp6 and Rrp47 in 
attempts at obtaining minimal regions of the proteins more readily useable for structural studies.   
 
4.1. Introduction 
 
The nuclear exosome is responsible for the maturation of rRNA, snRNA, and snoRNA, as well 
as the surveillance of mRNA and tRNA.  Unlike the yeast cytoplasmic exosome, however, the 
nuclear exosome associates with the additional nuclease Rrp6, which appears to be involved in 
the degradation of the 3’ precursor ends of snRNA and snoRNA, as well as some steps of rNRA 
maturation (1).  The distributive nature of the exonuclease activity of Rrp6 makes the enzyme a 
better candidate for maturation pathways, as opposed to Rrp44, which would instead likely 
degrade through the substrate and could potentially unwind structured regions as well.  However, 
Rrp6 is not an essential gene in yeast, so it is possible that Rrp44 can compensate for some of its 
roles in vivo.  Current knowledge of how Rrp6 binds to the exosome core is limited to a low 
resolution EM reconstruction of the trypanosome exosome (2), and yeast two hybrid studies (3).  
Therefore, a high resolution structure of the Rrp6 bound exosome would provide much insight 
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into how the nuclear exosome functions.  
 Nuclear RNA maturation appears to involve interplay of several different proteins with 
Rrp6.  The TRAMP complex has been proposed to activate the Rrp6 bound exosome for 
degradation, and the helicase Mtr4 has been shown to bind to Rrp6 in humans (4), but this 
association has not yet been established in other organisms.  Moreover, two small RNA binding 
proteins have been implicated in playing a role in RNA maturation in concert with the nuclear 
exosome.  Rrp47 is a 21 kDa basic protein that can heximerize and bind Rrp6 and RNA 
simultaneously (5).  It is involved in the maturation of of C/D box snoRNAs, and it appears to 
function in part by binding to proteins in snoRNP particles, suggesting that RNA maturation 
occurs after particle formation (6).  Another nuclear RNA binding protein, Mpp6, is a similar 
size and also highly basic.  It has been implicated in maturation of 5.8S rRNA (7), as well as in 
the surveillance of pre-rRNA and pre-mRNA and in the degradation of cryptic non-coding RNA 
(8).  Mpp6 has been shown to form a trimeric complex with Rrp6 and Mtr4 in human (4), but the 
conservation of such a complex and its function in the context of the exosome have not been 
determined. 
 In order to gain a better understanding of the nuclear exosome, we conducted structural 
studies of the Rrp6 bound exosome by negative stain EM reconstruction, and X-ray 
crystallography studies of Rrp47 and Rrp47-Rrp6 sub-complexes.  We also conducted pull-down 
assays and size exclusion chromatography experiments with various reported exosome 
associated proteins to determine their mode of interaction.  These studies were conducted in 
attempts of better characterizing the composition of the nuclear exosome during RNA 
degradation. 
 
4.2. Purification of Rrp6 containing yeast exosomes 
 
In order to study the Rrp6 bound exosome by EM reconstruction, we needed a practical protocol 
for purifying medium to large scale batches of the complex.  We initially tried using a TAP-Rrp6 
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yeast strain, and following a purification method similar to that mentioned in Chapter 3.2.  
However, the TAP-Rrp6 strain yielded approximately half the amount of cell paste of the TAP-
Rrp46 strain, and we were unable to obtain more than a small amount of the complex, which was 
not of sufficient purity for EM analysis.  Therefore, we instead reconstituted yeast purified 
exosomes with recombinant Rrp6 in order to form the complex.  This method had the added 
advantage that it also allowed us to engineer Rrp6 to remove flexible regions that could 
complicate EM analysis.  Our truncated Rrp6 comprised amino acids 129-670.  The N-terminal 
region of this truncation is based mainly on the border of the crystallized region of yeast Rrp6 
(9), as well as  a DISOPRED prediction (10), and data from a previous report that indicates that 
the C terminus of Rrp6 is required for exosome association, but the N-terminus is dispensable 
(11).   In order to initially determine that Rrp6 amino acids 129-670 bound to the exosome 
without wasting precious purified yeast exosomes, we used recombinant exosomes.  Although 
recombinant exosomes may not be as well assembled as their endogenous counterparts, they 
appear to bind Rrp6 in a similar fashion, as will be shown below. 
 
4.2.1. Methods 
Protein Expression and Purification 
The coding region for the Rrp6 truncation containing amino acids 129-670 was cloned into a 
pLIC kanamycin vector containing an N-terminal hexahistidine tag and expressed in E. coli 
using standard procedures detailed in earlier chapters.  It was then purified by Ni-NTA and 
MonoQ chromatography.  Recombinant and yeast-purified exosomes were prepared as detailed 
previously (Chapter 3.2). 
Association of Rrp6 129-670 with the exosome 
The association of Rrp6 129-670 with the exosome was initially tested by mixing recombinant 
core exosomes with Csl4 and Rrp6 in a 1:1.5:1.5 molar ratio and then separating the mixture on a 
Superose 6 size exclusion column run in 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT at a 
flow rate of 0.3 mL/minute.  Recombinant hexahistidine tagged Csl4 is added to the complex 
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because it was absent from the previous EM reconstruction and assumed to be substoichiometric 
in yeast purified exosomes (12).  The recombinant exosome + Csl4 and Rrp6 129-670 alone were 
run separately as size standards in a similar fashion.  In order to form complexes of Rrp6 with 
the yeast purified exosome for EM analysis, proteins were mixed in a 2:1 molar ratio of Rrp6: 
exosome, loaded onto a MonoQ column equilibrated with 20 mM Tris pH 8.0, 5 mM 
betamercaptoethanol, and 10% glycerol, and eluted with an increasing gradient of NaCl. 
 
4.2.2. Results 
After two step purification, Rrp6 129-670 still appeared as a series of three bands that ran with 
close migration (Fig.4.1A), that appear to result from either protein instability or proteolysis of 
the C-terminus during expression.  Since a smaller fragment was crystallized previously (amino 
acids 129-536) (9), it is likely that the region between amino acids 536 and 670 is unstable.  
However, it has been reported that this same region is important for exosome binding (11), so it 
is essential to avoid removing it for our studies.  When Rrp6 129-670 was run on Superose 6 
with recombinant exosomes, a peak centered at an elution volume of 13.5 mL was produced, 
which was an earlier elution than the core exosome alone, suggesting that an Rrp6-exosome 
complex was formed (Fig. 4-1B).  Subsequent SDS-PAGE analysis revealed that at least one  
Rrp6 species was contained in the peak (Fig. 4-1C).  Complex formation was also confirmed in a 
similar manner using the Rrp44 bound yeast purified exosome (not shown).     
Ultimately, although recombinant exosomes are useful for binding studies with Rrp6, 
they have previously been shown to incorrectly assemble under EM (13).  In order to produce 
more homogeneously assembled exosomes, we reverted to using yeast purified Rrp44 bound 
exosomes and reconstituting them with Rrp6 129-670.  Rrp6 129-670 was mixed with Rrp44 
containing yeast purified exosomes and then further purified on a MonoQ column, which was a 
more efficient method to simultaneously remove both RNA and unbound proteins than size 
exclusion chromatography.  The complex eluted around 330 – 360 mM NaCl, and SDS-PAGE 
analysis indicated that all exosomes contained Rrp6 129-670, and approximately half of the 
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Figure 4-1. Purification of Rrp6 129-670 and its association with the core exosome.  A) 
SDS-PAGE analysis of Rrp6 129-670 after Ni-NTA and MonoQ purification.  About 2-3 major 
protein bands migrate at a position similar to the molecular weight of Rrp6, suggesting partial 
proteolysis during purification.  ―M‖ is the molecular weight marker, and ―BL‖ is the before 
MonoQ column loading fraction.  B) Elution profiles of recombinantly purified core exosome 
and the core exosome containing Rrp6 after size exclusion chromatography on a Superose 6 
column. C) SDS-PAGE analysis of the Rrp6/core exosome complex after Superose 6 
chromatography. 
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exosomes also contained Ski7 (Fig. 4-2A).  Subsequent western blotting with a HISprobe 
antibody, which is specific for polyhistidine tags, unambiguously revealed the presence of Rrp6 
129-670 in the complex (Fig. 4-2B).  Interestingly, although Rrp6 129-670 initially appeared as 
three close migrating bands after purification, the exosome complex contains only the highest 
migrating Rrp6 species, which most likely contains the full 129-670 amino acids.  Additionally, 
two species that migrate between 35 and 40 kDa are identified in the blot.  One of these proteins 
is likely recombinant hexahistidine tagged Csl4, which migrates in this position.  The other 
species is probably a truncated form of Rrp6 that also appears in samples of Rrp6 129-670 alone 
(Fig. 4-1A). 
 
 
4.3. EM analysis of Rrp6 129-670 containing exosomes 
 
 
Since EM analysis requires a low concentration of sample, we had the luxury of picking single 
fractions from the MonoQ purification to test under EM.  The advantage of this method was that 
it allowed us to selective avoid fractions containing the endogenous Ski7 protein, which could 
complicate reconstruction methods.  EM analysis was conducted in collaboration with the 
laboratory of Hongwei Wang (Yale Medical School).  In the following section, the author of this 
manuscript preformed initial 2D reconstruction analysis on the samples, while Xueqi Liu, a 
postdoctoral fellow in the lab of Hongwei Wang performed 3D reconstruction analysis. 
 
4.3.1. Methods 
Protein was diluted to ~0.1 µM in buffer containing 25 mM HEPES pH 7.5, 50 mM NaCl, and 2 
mM DTT.  A volume of 4 µL of protein solution was cross-linked with 0.1% glutaldehyde for 
either 30 seconds or 1 minute.  Samples (native and cross-linked) were then negatively stained 
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Figure 4-2. Analysis of the Rrp6 containing exosome reconstituted from yeast proteins. A) 
SDS-PAGE analysis of the Rrp6 exosome after MonoQ purification.  The asterisk indicates a 
substoichiometric amount of Ski7 that was contained in some fractions.  B) Western Blot 
analysis of the Rrp6 exosome.  Fractions from the MonoQ purification of Rrp6 129-670 (Fig. 4-
1A) were compared to fractions from the Rrp6 bound exosome purification.  The exosome 
appears to contain mostly the full version of Rrp6 (amino acids 129-670) in the peak fraction 
(lane 8, fraction #75).  Secondary bands appear around 35 kDa: one is likely hexahistidine 
tagged Csl4, while the other is probably a smaller Rrp6 truncation.  
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with 2% uranyl acetate on a copper grid, blotted dry, and processed for EM imaging.  Exosome 
images were collected, and  data processing was completed using EMAN software (14). 
 
4.3.2. Results 
 
Exosomes appeared well assembled under EM analysis (Fig.4-3).  Cross-linking with a low 
percentage of glutaldehyde was used to allow Rrp6 to form a more stable association with the 
exosome and prevent flexibility.  Short cross-linking allowed for a homogeneous particle size 
under EM (Fig. 4-3A), while cross-linking for 1 minute produced aggregation (Fig. 4-3B), and 
produced exosomes exosome cores that were severely constricted (not shown). 
 Two-dimensional class averages of the Rrp6 bound exosome were produced using 
EMAN software (14).  Class averages are representative angles of view based on 
severalthousand individual exosome particles (Fig. 4-3C).  The central channel of the exosome is 
very distinguishable in most of the class averages displayed.  In some angles, a large extra 
density on the bottom of the RNase PH ring can be seen, which corresponds to Rrp44.  
Furthermore, quite a few views also indicate the presence of another density distal to Rrp44, 
which could be Rrp6 (Fig. 4-3C).  Despite the promising result from the 2D class averages, three 
dimensional analysis was needed to conform the location and conformation of Rrp6.  3D analysis 
was completed by Xueqi Liu using the samples mentioned here, as well as others prepared in a 
similar manner under a variety of different conditions.  Although an additional density was found 
on the top of the exosome ring in 3D reconstructions, it corresponded to Csl4 and not Rrp6, 
because the same density was later found in exosome preparations lacking Rrp6 (not shown).  
Unfortunately, the Rrp6 density was not able to be located during 3D reconstruction. 
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Fig.4-3. EM analysis of Rrp6 containing exosomes.  No or short crosslinking produces 
homogeneously assembled exosomes (A), while longer crosslinking results in aggregates (B).  C) 
Class averages obtained from Rrp6 containing exosomes.  The exosome core is clear in most 
angles.  Some angles also included a density on the bottom of the core that represent Rrp44, and 
a density on the top that likely was produced by Rrp6. 
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 Western blot analysis indicates that Rrp6 is clearly present in the exosome complex (Fig. 
4-2B) and 2D analysis also suggests the presence of a sizable density on the top of the exosome 
ring (Fig. 4-3C), which corresponds to a position where Rrp6 is likely to bind based on prior EM 
work (2) and yeast two-hybrid studies from different organisms (3).  Therefore, the absence of 
Rrp6 in 3D reconstructions likely results from flexibility of the subunit, resulting in it adopting 
different conformations.  This flexibility ultimately causes the Rrp6 density to average out during 
3D reconstruction, and this is likely why we were not able to locate it.   
The flexibility in Rrp6 could be reduced by a number of different methods.  The first 
would be to further truncate Rrp6 to remove flexible regions in the C-terminus of Rrp6.  This 
method, however, is complicated by the fact that a portion of this region appears to overlap with 
the binding site to the exosome (11).  An alternative method would be to form exosomes 
containing additional Rrp6 binding subunits in hopes that the binding of Rrp6 to these subunits 
would cause it to lock into a more rigid conformation, which would improve EM analysis.  In 
attempts towards this method, we explored the interaction of Rrp6 with other accessory nuclear 
proteins in the following section.       
 
4.4. Exploring protein interactions within the nuclear exosome 
 
 
Although Rrp6 is the hallmark subunit of the nuclear exosome, addition cofactors are also 
present.  In S. cerevisiae, Rrp6 forms a complex with Rrp47 that is mediated by interaction 
between the N-terminal regions of the two proteins (6).  Several complexes of Rrp47 and Rrp6 
were produced by co-expression in an attempt to lock down flexible regions of the proteins for 
facilitating reconstruction efforts of the Rrp6 bound exosome.  Additionally, interactions 
between Rrp6 and the proteins Mtr4 and Mpp6 have been reported in human cells (4).  
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Interactions between these proteins with Rrp6 and the core exosome were explored using GST 
pull-down assays and size exclusion chromatography analysis.  Any stable interactions between 
these proteins were then pursued by reconstitution of the protein into yeast purified exosomes for 
EM analysis.  
 
4.4.1. Methods 
Cloning, protein expression, and purification 
The coding sequences of the full length version of Rrp6 (amino acids 1-733) and C-terminal 
truncation of amino acids 1-660 were PCR amplified from yeast genomic DNA with a forward 
primer containing a 5’ end BamHI site and an N-terminal hexahistidine encoding region, and a 
reverse primer with a 3’ end XhoI site.  Full length Csl4 was amplified in a similar manner.   
Rrp6 and Csl4 sequences were then inserted into a pGEX4T1 vector (containing an N-terminal 
GST moiety and ampicillin resistance) with T4 DNA ligase.  Hexahistidine tagged Rrp6 1-660 
was additionally amplified with 5’ NcoI and 3’ XhoI primers and inserted into a pET19b vector 
containing ampicillin resistant.  Exosome core subunits or dimers of subunits were cloned and 
expressed as stated in section 3.1.  Mtr4 that was cloned into a pET 151-D-topo vector that 
contained an N-terminal TEV protease cleavable hexahistidine tag was kindly provided by Sean 
Johnson (Utah State University).  Coding regions for Mpp6 and Rrp47 were amplified from 
genomic DNA and cloned into a pSUMO vector using a 5’ BamHI and a 3’ XhoI restriction site.  
Ligation mixtures were transformed into DH5α cells.  All plasmids were selected on ampicillin 
resistant LB plates, with the exception of Mpp6 and Rrp47 which were selected for on 
kanamycin plates.  Plasmids containing Mtr4, Csl4, and Mpp6 were then transformed into 
BL21* cells for expression.  GST Rrp6 full length and 1-660 (GST and native version) were co-
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transformed with Rrp47 vectors for co-expression into Rosetta II cells (containing rare codons 
and chloremphenicol resistance) and selected on triple ampicillin, kanamycin, and 
chloremphenicol plates.  All cultures were grown in LB supplemented with the appropriate 
antibiotics at 37 °C and 200 rpm until reaching an OD600 of 1.0.  Cultures were then induced 
with 1 mM IPTG at 18 °C and 200 rpm overnight. 
 GST Rrp6 full length and 1-660 truncation (GST tagged and native) in complex with 
hexahistidine SUMO Rrp47 were purified by Ni-NTA, and dialyzed overnight into 20 mM Tris 
pH 8.0, 300 mM NaCl, 5 mM betamercaptoethanol, and 10% glycerol.  During dialysis, the N-
terminal hexahistidine SUMO tag on Rrp47 was cleaved with Sm3t SUMO protease.  The 
complex was then further purified by heparin chromatography.  Rrp47 alone was purified in a 
similar manner. Mtr4 and Mpp6 were purified by Ni-NTA using standard procedures, and the 
hexahistinde SUMO tag on Mpp6 was cleaved during overnight dialysis.  The proteins were then 
purified on either MonoQ (Mtr4) or heparin (Mpp6) chromatography, followed by size exclusion 
chromatography on a Superose 6 column.  For the Csl4 GST fusion, cell pellets were 
resuspended in 1XPBS, lysed by sonication, and applied to a 5 mL GSTrap column (GE 
Healthcare).   The column was then washed with 20 column volumes of 1XPBS and eluted with 
buffer containing 50 mM Tris pH 8.0, 100 mM NaCl, and 20 mM reduced glutothionine.  An 
empty pGEX41 vector was expressed and purified in a similar manner to serve as a control.  
Proteins were concentrated and flash frozen and stored at -80 °C. 
GST Pulldown Assays 
An amount of 50 µg of GST tagged protein (Rrp6, Csl4, or free GST as a control) was mixed 
with 50 µg of bait protein and diluted up to 100 µL with Binding Buffer (1XPBS containing 1 
mM DTT).  The mixture was then applied to 50 µL of glutathione beads in a 1.5 mL centrifuge 
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tube equilibrated with Binding Buffer.   The mixture was incubated with the beads at 4 °C for 2 – 
4 hours with gently rocking.  The tube was then spun and the supernatant was collected.  The 
beads were washed three times each with 1 mL of Binding Buffer, and eluted with 125 µL of 50 
mM Tris pH 8.0, and 20 mM reduced glutathione.  Elutions were run on 10% SDS PAGE gels 
and visualized with Coomassie Blue staining. 
Size Exclusion Chromatography 
Mtr4 and Mpp6 were run either separately or in combination through a Superose 6 column 
equilibrated with 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT at a flow rate of 0.3 
mL/minute.  Fraction sizes of 0.250 mL were collected for analysis. 
Complex Formation with yeast purified exosome 
The untagged Rrp6 1-660/Rrp47 complex was mixed with yeast purified exosomes in a 2:1 
molar ratio and dialyzed overnight into 20 mM HEPES pH 7.5, 75 mM NaCl, and 2 mM DTT.  
The mixture was then applied to a 1 mL MonoQ column, run using dialysis buffer, and eluted 
with an increasing gradient of NaCl.  Peak fractions were analyzed by SDS-PAGE to ascertain 
complex formation.  An exosome complex with Mpp6 was attempted in a similar manner. 
 
4.4.2. Results 
 
Stable complexes between all Rrp6 truncations tested with full length Rrp47 were clearly formed 
since both proteins were present during SDS-PAGE analysis after all steps of purification, 
despite the fact that only Rrp47 contained a hexahistidine tag and that purification was 
performed in high salt conditions (300 mM NaCl) during Ni-NTA chromatography.  Notably, 
Rrp47 aided in the purification of full length Rrp6.  Full length Rrp6 alone expresses poorly 
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except when fused to a SUMO tag, and even then yield of the protein is very low (15).  However, 
the Rrp6 full length/Rrp47 expressed well with a good yield and decent final purity.   
Pull-down assays were first conducted with GST-Csl4 using the recombinant expressed exosome 
and Rrp47 as bait.  GST-Csl4 was able to pull-down all subunits of the exosome, while GST 
alone did not (Fig.4-4A lanes 1 and 2), but it did not pull-down Rrp47, indicating that this 
protein solely interacts with Rrp6.  The GST-Rrp6 1-660/Rrp47 complex was also able to pull 
down all exosome subunits (Fig. 4-4A lane 7), indicating that the complex likely binds to the 
exosome in a manner similar to the previously truncation Rrp6 129-670.  The GST-Rrp6 1-
660/Rrp47 complex, however, failed to pull down any of the RNA binding subunits of the 
exosome alone (Rrp4, Rrp40, or Csl4), or any individual heterodimer (Rrp41/Rrp45, 
Rrp43/Rrp46, or Rrp42/Mtr3) or Rrp44 (results not shown).  Therefore, Rrp6 likely binds at the 
interface between different heterodimers and/or capping subunits, making the exact location of 
its binding difficult to decipher. 
 Neither the GST Rrp6 full length/Rrp47 or the GST Rrp6 1-660/Rrp47 complexes pulled 
down Mpp6 (Fig. 4-4A lanes 6 and 11) or Mtr4 (Fig. 4-4A lane 5) alone.  The core exosome was 
also not able to pull down Mtr4 (Fig. 4-4A lane 9).    However, GST-Csl4 pulled down Mpp6 
when mixed with the core exosome (Fig. 4-4A lane 12), and a similar result was observed when  
GST-Rrp6 1-660/Rrp47 was mixed with the core exosome and Mpp6 (lane 3).  This indicates 
that Mpp6 makes most of its interactions with the core exosome, and not Rrp6 in S. cerevisiae.  
There were no interactions detected between Mpp6 and Mtr4 as determined by size exclusion 
chromatography experiments (Fig. 4-4B-C). 
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Fig. 4-4. Nuclear exosome protein interaction studies.  A) GST pull-down experiments, 
depicting fractions eluted from GST binding resin.  B) Size exclusion chromatography profiles of 
Mtr4 and Mpp6 run on a Superose 6 column.  C) SDS-PAGE analysis of size exclusion 
chromatography preformed by combining Mtr4 and Mpp6.  No indication of complex formation 
was detected.  The first lane of the gel contains the before loading (BL) sample.   
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Based on the results of GST pull-down and size exclusion chromatography experiments, 
reconstitution of yeast exosomes containing either the Rrp6 1-660/Rrp47 complex or Mpp6 was 
attempted.  Although Rrp6 1-660 is clearly present in the exosome, the Rrp47 band appears 
rather faint in SDS-PAGE analysis (Fig. 4-5) so it is difficult to tell whether the protein is 
stoichiometric in the complex or not.  It was even more difficult to indicate the presence of Mpp6 
within the exosome since lower concentrations of proteins were used for this experiment (result 
not shown).  Both complexes were subjected to EM analysis, but interpretable density was not 
observed for Rrp6, Rrp47, or Mpp6 (13).  It is likely that Mpp6 is too small to produce 
pronounced density in EM analysis.  The protein appears to run in a position suggesting a 
monomer instead of forming an oligomer (Fig. 4-4B, compare the 20 kDa Mpp6 to the 122 kDa 
protein Mtr4).  It is surprising that no density was observed for Rrp47, which has been reported 
to form a hexamer (5), and thus should produce a large observable density.  It is possible that 
Rrp47 dissociates during negative stain conditions, or is substoichiometric during intial 
purification, which would explain its absence during EM analysis 
 
4.5.  Structural Studies of Rrp47 and the Rrp6/Rrp47 complex 
 
 
Structural studies were initiated on Rrp47, an RNA binding protein that binds to Rrp6 and is 
involved in processing and snRNA and snoRNA (16).  Rrp47 contains a Sas/C1D domain that is 
predicted to be predominately alpha helical in nature, which is involved in nucleic acid binding 
(17).  Other than its role in exosome associated degradation, Rrp47 has been implicated in 
regulation of DNA repair in mammals (18).    Rrp47 is of particular interest because the structure 
of the Sas/C1D domain has not been determined from any protein homologue.   
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Figure 4-5. Reconstitution of the Rrp6 and Rrp47 containing exosome.  Yeast exosomes 
were mixed with recombinant Rrp6 1-660/Rrp47 complex and purified on MonoQ 
chromatography.  Peak fractions were analyzed on SDS-PAGE.  While Rrp6 1-660 is easy to 
identify, Rrp47 is barely noticeable in the gel. 
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Although Rrp47 has a molecular weight of only 21 kDa, it migrates at a position closer to 120 
kDa during size exclusion chromatography (5), indicating that it likely forms a hexamer.  Our 
primary structural target was S. cerevisiae Rrp47, although it was somewhat of a problematic 
target given that it contains a fairly disordered C-terminus, based on a DISOPRED prediction 
(10) (Fig. 4-6B).  A protein that also binds to human Rrp6 and appears to have a function similar 
to Rrp47 was identified as C1D (but here referred to as human Rrp47) (4).  Interestingly, the two 
proteins have very little sequence identity with the exception of a few speckled regions, and 
human Rrp47 is 43 amino acids shorter than its yeast counterpart (Fig. 4-6A).  Nonetheless, 
human Rrp47 is well conserved in mammals—based on a ClustalW (19) sequence alignment—
indicating the possibility of a conserved functional role in exosome mediated degradation. 
Although human Rrp47 also contains disordered regions (Fig. 4-6C), its shorter length could 
make it an easier structural target.  Numerous constructs of yeast and human Rrp47 were 
produced in attempts at obtaining diffracting crystals of Rrp47.  Protein modification methods 
such as in situ proteolysis and lysine methylation were attempted in order to produce better 
diffracting crystals.  In addition, complexes between Rrp6 and Rrp47 were also attempted for 
crystallization.   
 
4.5.1. Methods 
Target Selection 
The full length versions of both the yeast and human Rrp47 were attempted, along with several 
truncations (Table 4-1).  Truncation selection was initially based on disorder prediction (Fig. 4-
6B-C).  Truncations removed a varying degree of the C-terminus of Rrp47, which is fairly 
168 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-6.  Alignment of yeast and human Rrp47, and disordered regions.  A) Alignment of 
the two proteins.  In general, there is little sequence conservation between the two proteins, with 
the exception of a few amino acids.  Notably, yeast Rrp47 also contains two long insertions 
(yeast amino acids 100-127 and 150-164).  Both proteins are lysine rich.  The alignment was 
preformed with ClustalW (19).  B) Prediction of disordered regions in yeast Rrp47 and C) human 
Rrp47.  Disordered predictions were preformed with the DISOPRED prediction server (10). 
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Truncation 
yRrp47 FL 
yRrp47 1-93 
yRrp47 1-119 
yRrp47 8-133 
yRrp47 1-148 
yRrp47 8-83 
yRrp47 32-132 
hRrp47 FL 
hRrp47 1-123 
hRrp47 8-123 
hRrp47 8-end 
 
Table 4-1. Truncations of Rrp47 for use in crystallization screening.  The table lists 
truncations of yeast (y) or human (h) Rrp47 attempted for crystallizations. 
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disordered.  Later truncations were based on limited proteolysis data (discussed later).  
Truncations of Rrp6 were based on the C-terminal boundary of the crystallized fragment (9) (1-
536), the region shown to bind to the exosome (11) (1-660), and a minimal region required for 
binding to Rrp47 (5, 6) (1-176).  
Cloning and Expression 
S. cerevisiae and human Rrp47, as well as all truncations were PCR amplified using primers 
containing a 5’ end BamHI site for the yeast version, or a SacI site for the human version, and a 
3’ end XhoI site.  Yeast genomic DNA served as a template for the S. cerevisiae Rrp47, and 
cDNA from MCF-7 cells served as the template for the human version.   Inserts were cleaved 
with BamHI (or SacI) and XhoI and ligated into vectors containing an N-terminal hexahistidine 
SUMO fusion (pSUMO) and kanamycin selective marker.  Plasmids were then transformed into 
DH5α cells and grown on LB plates supplemented with kanamycin.  The full length version of 
Rrp6, as well as several truncations (amino acids 1-176, 1-660, and 1-536), were cloned into 
pET19b vectors as discussed in Section 4.4.  Colonies were mini-prepped, and the presence of 
the correct insert was determined by DNA sequencing.  Rrp47 plasmids were then transformed 
into BL21* cells or Rosetta II cells, either alone or co-transformed with Rrp6.  Cultures were 
grown in 2-4 L of LB supplemented with 25 µg/mL of kanamycin and 34 µg/mL 
chloramphenicol (as well as 100 µg/mL ampicillin for co-transformants) and grown at 37 °C and 
200 rpm until reaching an OD600 of ~1-1.7.  At this point, cells were induced with 1 mM IPTG 
and incubated at 18 °C and 200 rpm overnight. 
Protein Purification 
Cells pellets were resuspended in Binding Buffer containing 50 mM sodium phosphate, 300 mM 
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NaCl, 10 mM Imidazole, 5 mM betamercaptoethanol, 10% glycerol, and 1 mM PMSF.  Cells 
were lysed by sonication and pelleted to remove cell debris.  Supernatant was run through a Ni-
NTA column, the column was washed with 10 column volumes of Binding Buffer, and eluted 
with Elution Buffer (Binding Buffer containing 300 mM Imidazole).  Both yeast and human 
Rrp47 were very salt sensitive and precipitated out of solution readily when dialyzed into low 
salt buffer overnight.  Therefore, proteins were dialyzed into 20 mM Tris pH 8.0, 300 mM NaCl, 
5 mM betamercaptoethanol, and 10% glycerol overnight at 4 °C, and the NaCl concentration was 
never reduced below 300 mM during further purification steps to avoid protein precipitation.  
During dialysis, the SUMO tag was cleaved with Sm3t SUMO protease.  Rrp6/Rrp47 complexes 
were prepared in a similar fashion, but appeared less salt sensitive.   
Yeast Rrp47 full length was re-run through a nickel column, followed by a heparin 
column equilibrated with dialysis buffer and eluted with a gradient of 300 mM – 2 M NaCl.  The 
best protein purity was obtained by performing Sephacryl S-100 size exclusion chromatography 
in buffer containing 20 mM Tris pH 8.0, 500 mM NaCl, 10% glycerol, and 2 mM DTT.  The 
protein was dialyzed into 20 mM HEPES pH 6.0, 300 mM NaCl, 10% glycerol, and 2 mM DTT 
and then run through a MonoS column in this buffer, and eluted with a gradient of 300 mM – 1 
M NaCl (Fig. 4-7A).  However, some batches were produced to sufficient purity without the use 
of the last two steps.  Initially, protein was concentrated to 9-10 mg/mL for crystallization 
screening, although higher concentrations could be obtained in subsequent purifications.     
Human Rrp47 was further purified by heparin and run on a Sephacryl S-100 size 
exclusion column in buffer containing 20 mM Tris pH 8.0, 300 mM NaCl, and 1 mM DTT.  The 
protein was then concentrated in this buffer to 39.5 mg/mL.  Purification of truncated forms of 
the yeast and human Rrp47 were attempted using methods similar to the full length versions.  
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Rrp6/Rrp47 complexes were further purified by heparin and eluted with a gradient of NaCl, 
followed by a final purification on a Superdex 200 column. 
Limited Proteolysis 
In order to find more stable truncations of Rrp47, limited proteolysis analysis was conducted, 
mainly with yeast Rrp47, as follows.  The proteolysis reaction was conducted in a volume of 100 
µL in buffer containing 125 mM Tris pH 8.0, 500 mM KCl, 12.5 mM magnesium acetate, and 
12.5 mM CaCl2. About 60 µg of Rrp47 was incubated with 60 ng of trypsin, chymotrypsin, or 
elastase, and incubated at room temperature.  Aliquotes of 10 µL of the mixture were withdrawn 
at various time points, mixed with an equal volume of SDS-PAGE loading dye, and heated at 65 
°C for 10 minutes to denature the protease.  Samples were then run on 15% acrylamide gels and 
stained with colloidal coomassie blue stain to visualize protein.  Bands of interest were cut out 
and analyzed by mass spectrometry. 
Crystallization Screening 
Screening was performed using nanoscale conditions with a Phoenix crystallization setup robot.  
Yeast Rrp47 was initially screened at 10 mg/mL, while human Rrp47 was screened at 10, 20, 
and 39 mg/mL.   
In-situ proteolysis crystallization  
While work on cloning of various Rrp47 truncations commenced, crystallization screening of 
full length versions of yeast and human Rrp47 was conducted using the in-situ proteolysis 
technique (20, 21) with elastase, since it was the only promising protease from the previous in-
vitro proteolysis experiments.  Elastase was mixed with proteins in molar ratios of 1:100, 
1:1,000, and 1:10,000, and incubated on ice for 30 minutes.  The mixture was then set up in 
nanoscale crystallization trials using the JCSG+ and Proplex crystallization condition suites. 
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Lysine Methylation 
Lysine methylation was completed based on the published protocol (22).  Briefly, protein was 
diluted into 50 mM HEPES pH 7.5 and 300 mM NaCl to a final concentration of about 1 mg/mL.  
Amounts of 20 µL of 1 M dimethylamine-borane complex and 40 µL of 1 M formaldehyde were 
added per mL of the protein solution, and the solution was incubated at 4 °C for 2 hours.  This 
process was then repeated once, followed by a final addition of 10 µL of 1 M dimethylamine-
borane complex and overnight incubation at 4 °C.  The protein was then purified on a Sephacryl 
S-100 column.  
RNA degradation assay 
A quick but low resolution method was used to determine whether the Rrp6 full length/Rrp47 
complex retained nuclease activity.  For the nuclease assays, 1.8 µM of unfolded HDV40 RNA 
was incubated with 1.4 µM of protein in buffer containing 25 mM Tris pH 8.0, 50 mM NaCl, 
10% glycerol, and 2 mM DTT, and 5 mM of either MgCl2, MnCl2, or ZnCl2.  A time course was 
conducted and aliquots were removed at either 10, 30, or 60 minutes, and the reaction was 
stopped by addition of 2X RNA loading dye followed by heating at 65 °C for 10 minutes.  
Samples were then resolved through a10% acrylamide/8 M urea gel and visualized by ethidium 
bromide staining.  
 
4.5.2. Results  
 
Both full length versions of yeast and human Rrp47 could be purified to near homogeneity (Fig. 
4-7A), and were soluble as long as the concentration of NaCl in the protein buffer was keep at 
300 mM or higher.  Notably, both proteins migrated at a position much higher than expected  
175 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-7. Purification, proteolysis, and crystallization of Rrp47.  A) Purity of yeast (left) 
and human (right) Rrp47.  B) Size exclusion chromatography of yeast and human Rrp47 on a 
Superose 6 column.  C) Limited proteolysis of yeast Rrp47 with elastase.  D) Typical crystal 
clusters of Rrp47 produced from in situ proteolysis with elastase in crystallization conditions of 
100 mM sodium acetate pH 4.6, 2.0 M ammonium sulfate.      
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based on their molecular weight during size exclusion chromatography, indicating the likelihood  
of oligomerization (Fig. 4-7B).  No crystal hits were observed for the full length versions of 
either protein, although many wells did contain heavy phase separation, indicating that 
crystallization was still a possibility. 
Prior disordered prediction analysis as well as limited proteolysis with elastase identified 
several truncations of Rrp47, which were produced in a manner similar to the full length version.   
While proteolysis with trypsin and chromtrypsin did not produce any stable intermediates, 
proteolysis with elastase produced two bands that could represent stable intermediates (Fig. 4-
7C), fragments of amino acids 8-83 and 8-133.  However, for an unknown reason, the majority 
of truncations purified appeared to be severely degraded after SUMO cleavage.  Moreover, most 
truncations removed disordered lysines, which subsequently altered the predicted isoelectric 
point of the protein from highly basic (pI ~10) to only slightly basic (pI ~8).  The drastic change 
purification on heparin difficult, resulting in lower purity.  Of the initial yeast Rrp47 proteins 
purified, only the truncation containing amino acids 1-93 was of sufficient quality to use for 
screening.  However, screening with this truncation did not produce crystals, with the exception 
of salt crystals present in conditions containing calcium. 
In situ proteolysis with elastase, however, was somewhat more successful.  Yeast Rrp47 
produced crystal clusters in some conditions for all ratios of protease tested, while human Rrp47 
did not produce any crystals.  Crystals were clusters of ―disks‖ (Fig. 4-7D) and appeared in the 
following two conditions: 1) 100 mM sodium acetate pH 4.6, 2.0 M ammonium sulfate, and 2) 
1.0 M LiCl2, 100 mM sodium citrate pH 4.0, 20% PEG 6,000, as well as conditions that 
contained variations of these two precipitants.  Crystals possessed a high degree of birefringence 
upon rotation of polarized light, and readily stained blue with Izit methylene blue solution 
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(Hampton Research), a protein dye.  Since crystals appeared even at very low ratios of elastase 
(1:10,000), it was unlikely that they were protease crystals.  Crystals were easily reproduced 
using large well hanging drop trays, and were optimized by standard methods of varying the pH 
of buffers and the concentrations of precipitants.  While optimization could be used to produce 
larger crystals, the crystals still retained a disk-like or cluster shape.  Interestingly, similar 
crystals could be produced when elastase was substituted for trypsin.  The crystals were 
thoroughly washed, dissolved in 1 M Tris pH 8.0, and analyzed by mass spectrometry, which 
indicated that the crystals contained Rrp47 amino acids 32-132.  The Rrp47 truncation amino 
acids 32-132 was cloned, expressed, and purified using a similar procedure to that of the full 
length version.  However, this truncation also appeared to suffer from degradation during 
purification and did not crystallize alone.  It only produced crystals with a similar morphology to 
the full length version when in the presence of elastase.  Multiple crystals were tested for 
diffraction at CHESS using different cryo-protectants, but no diffraction was ever obtained.    
Further optimization was performed with the full length Rrp47 in the presence of a 
minimal amount of elastase or trypsin.  Both seeding into optimized conditions as well as into 
random conditions was unsuccessful at producing crystals with a different morphology.  Since 
the protein is lysine rich, lysine methylation (22) was attempted in hopes of producing more well 
ordered crystals.  In general, lysine methylated crystals grew slower than their native 
counterparts but only under the presence of protease and retained the same disk shape.  They 
were not suitable for diffraction.   
Some batches of various truncations of Rrp47 were also tested for crystallization under in 
situ proteolysis without prior removal of the N-terminal SUMO tag.  While it was possible to 
achieve very high solubility of these proteins (upwards of 40 – 60 mg/mL concentrations), they 
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did not crystallize alone and produced crystals that looked identical to those produced without 
the tag when in situ proteolysis was used.  These crystals were tested at CHESS, but no 
diffraction whatsoever was produced after testing multiple crystals in various cryo-protectants.   
The Rrp6/Rrp47 complex also served as a crystallization target.  All complexes eluted as a single 
sharp peak during heparin chromatography, suggesting the existence of a single complex.  
During size exclusion chromatography, the Rrp6 full length/Rrp47 complex eluted at a volume 
of ~12 mL, which is consistent with a molecular weight of full length Rrp6 and a hexameric 
Rrp47 complex (Fig. 4-8A).  Complexes of Rrp47 with the truncated version of Rrp6 eluted at 
volumes consistent with a ratio of Rrp6 to Rrp47 of 1:6 as well (Fig. 4-8A).  While the complex 
containing full length Rrp6 and the 1-536 produced a single peak during size exclusion 
chromatography, complexes containing truncations 1-660 and 1-176 produced two overlapping 
peaks.  Therefore, it is possible that the latter complexes are composed of a varying mixture of 
Rrp47, although the peak doubling could also just be an effect of column over-loading (Fig. 4-
8A).  
 To test whether the Rrp6 full length/Rrp47 complex retained nuclease activity, it was 
subjected to a nuclease assay with various divalent cations (magnesium, manganese, or zinc).  
Rrp6 displayed robust activity with either magnesium or manganese, but no activity when zinc 
was used (Fig. 4-8C).  This indicates that the recombinantly purified Rrp6/Rrp47 retained its 
biological activity, and therefore is properly folded.  Although all mentioned Rrp6/Rrp47 
complexes were subjected to crystallization screens, none produced crystals.  This suggests that 
remaining flexible regions on Rrp6 or Rrp47 may be impeding crystallization.  
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Figure 4.8. Analysis of Rrp6/Rrp47 complexes.  A) Size exclusion chromatography of 
Rrp6/Rrp47 complexes on Superdex 200.  B) SDS-PAGE analysis of complexes after three step 
purifications.  Elution volumes of the peaks are labeled (in mL) with arrows.  C) Activity assay 
of Rrp6 full length/Rrp47 on unfolded HDV40 ribozyme using various metal ions.  Due to low 
resolution of this method, end products cannot be visualized. 
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4.6. Discussion 
 
In order to gain insight into the organization of the nuclear exosome, we have been able 
to reconstitute the Rrp6 containing exosome and conduct preliminary EM analysis on it.  While 
both western blotting and 2D reconstructions indicate the presence of Rrp6 in the complex, 
density for Rrp6 is lost during 3D reconstruction.  It is possible that Rrp6 dissociates during 
negatives stain preparation, indicating that Cryo-EM may be a better alternative.  While this 
technique has been tried with the Rrp6 exosome by our collaborators, so far it has been 
unsuccessful (13).  The other possibility is that Rrp6 is flexible and the density for it thus 
averages out.  While our efforts at using cross-linking reagents to prevent flexibility were not 
successful, more advanced techniques could be attempted.  In particular, a preparation technique 
called GraFix, in which a cross-linking gradient is coupled to a density gradient, could be useful 
(23).  This technique allows for the selection of individual fractions from the density gradient to 
be used for EM analysis, allowing for the removal of aggregated fractions. 
Our protein interaction analysis of the nuclear exosome revealed that accessory proteins 
interact with the yeast exosome in a manner different than the human exosome. While it was 
reported that human Mtr4 bound to both Rrp6 and Mpp6 to form a trimeric complex (4), our data 
do not support these results for S. cerevisiae.  Instead, we detect binding between Mpp6 and the 
core exosome, but no interaction between Mtr4 with Rrp6, Mpp6, or the core exosome.  
Therefore, it is quite possible that the human proteins have diverged significantly from the yeast 
homologues.  Moreover, the human exosome has been reported to form the larger NEXT 
complex (24) which is not known to associate with the exosome in yeast.  It is, however, a bit 
curious that Mpp6—a nuclear protein—associates with the general core exosome instead of the 
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nuclear specific cofactor Rrp6.  In theory, Mpp6 could also associate with the cytoplasmic 
exosome, but the protein has only been detected in nuclear exosome fractions.  The simplest 
explanation is that since Mpp6 contains a nuclear localization signal it is restricted from the 
cytoplasm, preventing it from associating with the cytoplasmic exosome.  Therefore, Mpp6 
could serve to tether substrate RNA to either the exosome or Rrp6 without making protein 
contacts with Rrp6 itself.  Further structural and functional studies would help to resolve this 
mechanism. 
Our studies do confirm an interaction of Rrp6 with Rrp47 that is stable even under high 
salt conditions used during purification.  We have been able to co-purify several Rrp6/Rrp47 
complexes, and have produced crystals of yeast Rrp47.  While it is promising that Rrp47 
produced some crystals when proteolyzed by elastase, the crystals appear to be poorly ordered 
and do not diffract at all.  Since Rrp47 has been reported to form a hexamer, it is possible that 
when protease is added, heterogeneous hexamers, consisting of monomers of Rrp47 truncated at 
different positions, are formed and crystallize.  However, these crystals are likely to be poorly 
ordered and thus do not diffract.   Since the Rrp47 fragment of amino acids 32-132, identified by 
mass spectrometry analysis of the crystals, only crystallized in the presence of protease as well, 
crystallization may be dependent on the cleavage of internal loops instead of N- or C-terminal 
disordered regions.  Therefore, locating predicted flexible loops and systematically deleting them 
may aid in producing better diffracting crystals.  The caveat here is that truncating Rrp47 has 
been shown to result in protein instability and degradation, so it is likely that many different 
truncations of internal loops will need to be screened in order to find one that both retains protein 
stability and crystallizes.  Another option to improve stability is to try co-crystallizing truncated 
Rrp47 with Rrp6.  However, this will likely require a bit of trial and error, since an Rrp47 
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truncation lacking only the first eight N-terminal amino acids failed to pull-down Rrp6 during 
co-expression (data not shown).   Therefore, it is likely that more effort in protein engineering of 
Rrp47 (and possibly Rrp6) is needed in order to produce crystals suitable for X-ray diffraction.  
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Appendix 
 
Studies of Ski7: a GTPase that associates with the cytoplasmic exosome and functions in 
mRNA surveillance 
 
Abstract 
This appendix details the purification and crystallization attempts of Ski7, a cytoplasmic 
exosome associated protein.  Although the full length version of the protein appeared toxic to E. 
coli cells, we were able to purify the C-terminal region of the protein (amino acids) to sufficient 
yield for crystallization screening. 
 
A1.1. Introduction 
 
Ski7 is a protein that has been reported to bridge interactions between the cytoplasmic exosome 
and the SKI complex to function in mRNA surveillance.  Since it has sequence homology to the 
previously crystallized regions of S. cerevisiae EF1A and the C-terminal region of S. pombe 
eRF3, this homology region (Ski7 amino acids 250-747) served as the primary structural target.  
EF1A is involved in bringing aminoacylated tRNA to the ribosome and eRF3 is involved in 
peptide release after translation and has a GTPase activity that is stimulated by association with 
the ribosome and the eRF1 protein cofactor.  Theories speculate that Ski7 may also function in 
peptide release during mRNA surveillance, given that its C-terminus is homologous to eRF3.  
We attempted a structural approach to better characterize the role of Ski7.  The following 
strategies were used in attempts to purify and crystallize the C-terminal region of Ski7. 
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A1.2. Methods 
Cloning 
Previous studies indicated that Ski7 did not express in typical expression vectors, possibly due to 
toxicity of the protein to E. coli (Ke lab, unpublished data).  Therefore, Ski7 was instead cloned 
into a pBAD vector, which contains more stringent control over expression by the inducer 
arabinose.  Ski7 full length as well as truncations (1-255, 200 – 747, 260 – 747, and 250 – 747) 
were PCR amplified using a 5’ primer containing a NcoI site and N-terminal hexahistidine 
region, and a 3’ primer with a XhoI site and inserted into a pBAD vector linearized with NcoI 
and XhoI restriction enzymes.  DNA was sequenced to confirm the correct insert.  The proteins 
were initially purified by Ni-NTA chromatography, followed by ion exchange.  While the full 
length and N-terminal (1-255) truncations did not expressed, C-terminal truncations expressed to 
a certain extent.  The best protein quality and yield was obtained for Ski7 250 – 747.  The 
following protocol is an optimized method for preparing batches of Ski7 250 – 747 of sufficient 
purity and quantity for crystallization attempts.  
Expression and Purification 
A volume of 10 L of LB was inoculated with 1 mL of Ski7 250 – 747 overnight culture/L and 
supplemented with 100 µg/mL of ampicillin.  Cultures were grown at 37 °C until reaching an 
OD600 of 1.0.  Cultures were then induced with 10 mL of 20% arabinose at 37 °C and induced 
for ~8 hours at 37 °C.  Cultures were induced at 37 °C instead of 4 °C because low temperature 
induction resulted in a high migrating contaminant after SDS-PAGE analysis that was suspected 
to be a chaperone that could have resulted from cold shock to the bacteria.  Cells were pelleted, 
snap frozen, and stored at -80 °C until use. 
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 For purification, cells were thawed and resupsended in a total volume of 150 mL with 
Buffer A (50 mM sodium phosphate pH 8.0, 300 mM NaCl, 10 mM imidazole, 10% glycerol, 5 
mM betamercaptoethanol, 10 µg/mL DNaseI, and 1X protease inhibitors).  Cells were lysed by 
sonication and centrifuged to pellet cell debris.  Supernatant was then loaded onto Ni-NTA resin 
equilibrated in Buffer A.  Resin was then washed with 50 mL of Buffer A, followed by 30 mL of 
Buffer A containing 20 mM imidazole.  Protein was eluted with Buffer A containing 250 mM 
imidazole.  Imidazole was removed and NaCl reduced by dialysis into 20 mM Tris pH 8.0, 50 
mM NaCl, 10% glycerol, and 5 mM betamercaptoethanol overnight at 4 °C. 
        Since Ski7 250 – 747 had previously been shown to precipitate on a MonoQ column during 
loading, the protein was instead subjected to a Q fast flow column (GE Healthcare), and loaded 
in three rounds with a reduced protein concentration per round.  After this step, protein was 
mostly pure, with the exception of a contaminant that ran at a molecular weight of ~75 kDa.  
This contaminant was effectively removed by concentrating the protein and running it through 
size exclusion chromatography on a Sephacryl S-100 column, equilibrated in 20 mM Tris pH 
8.0, 2 M NaCl, 10 % glycerol, and 2 mM DTT.  After size exclusion chromatography, the 
protein was judged to be ~99% pure by SDS-PAGE (Fig. A-1).  Peak fractions were pooled and 
dialyzed into 20 mM Tris pH 8.0, 200 mM NaCl, and 2 mM DTT, which was the final buffer for 
crystallization screening.  Ski7 truncations 200-end and 260-end were prepared in a similar 
fashion, but their final yields were too low for crystallization screening. 
Initial Crystallization screening 
Ski7 250 – end was concentrated to 18.2 mg/mL and initially set up in crystallization trays at 
concentration of 12 and 8 mg/mL at room temperature and at 4 °C.  Since Ski7 has 250 – 747 is 
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homologous to GTPase proteins, crystallization was also attempted in the presence of 2 mM 
MgCl2 and either GTP or GDP at both room temperature and 4 °C.   
Optimal Solubility Method Screening 
One issue with the protein was that it precipitated out of solution readily when it was let sit for 
~30 minutes on ice at concentrations of 5 – 8 mg/mL.  It was therefore thought that the protein 
may be poorly soluble in the buffer in which it was concentrated (20 mM Tris pH 8.0, 200 mM 
NaCl, and 2 mM DTT).  Screening using the optimal solubility (OS) method was attempted 
according to the published protocol (1).  Briefly, 1 µL of protein was mixed with 1 µL of various 
buffers at 100 mM concentration at different pH, and incubated in a hanging drop format over a 
reservoir of the same buffer.   
A1.3. Results 
None of the initial crystallization screens produced crystals in either the presence or absence of 2 
mM MgCl2, GTP, or GDP at room temperature or 4 °C incubation.  Most conditions produced 
heavy precipitation.  Of 24 buffers tested for the OS method, only three did not produce 
precipitation after overnight incubations: 100 mM solutions of glycine at pH 3.0 and CHES at 
pH 9.0, and 9.5.  Since extremely low pH solutions can denature proteins, CHES at pH 9.0 was 
chosen as a good buffer to use to help to keep the protein soluble.  Another batch of Ski7 250 – 
747 was purified using a similar protocol to that described, but the final size exclusion step was 
instead preformed in 20 mM CHES pH 9.0, 150 mM NaCl, and 2 mM DTT.  The protein was 
concentrated to ~11 mg/mL and screened for crystallization.  While the solubility of the protein 
was greatly improved, no crystals were produced and many conditions remained clear. 
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Figure A-1. SDS-PAGE analysis of Ski7 250-747 after three purification steps. 
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A1.4. Discussion 
Although the yield of Ski7 during purification is low, we were able to obtain a large amount of 
protein suitable for crystallography studies of a truncation comprising amino acids 250 – 747, 
and smaller batches of other truncations (260 – 747 and 200 – 747).  However, precipitation 
occurred readily in Ski7 250 – 747 at protein concentrations of 6 – 8 mg/mL or higher.  Although 
the protein was more soluble in mM CHES pH 9.0, 150 mM NaCl, and 2 mM DTT, no crystals 
were produced during screening in this buffer either.  
We were not able to purify either the full length version or the N-terminal region of Ski7 
which limited our studies of the Ski7 bound exosome.  Although the C-terminal truncations of 
Ski7 were tested for their ability to bind to the exosome core, no stable association was 
established (data not shown), which agrees with previous results that suggest that the N-terminus 
of Ski7 appears to be the major site of attachment to the exosome (2).  A batch of Ski7 
truncations 200 – 747 and 260 – 747 was tested for GTPase activity and shown to be an active 
GTPase by Chris Shoemaker of Johns Hopkins (personal communication).  Moreover, this 
activity was not stimulated by either the ribosome or other cofactors, and we were not able to 
find a stable association between Ski7 and either amino acylated tRNA or the ribosome (Chris 
Shoemaker, personal communication).  Therefore, as far as we know, Ski7 does not appear to 
function in a similar manner to either EF1A or eRF3.  However, further studies will need to be 
conducted to determine the exact role of Ski7 in exosome mediated degradation.         
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